JPS609516B2 - Cyclization method for Cefem skeleton - Google Patents
Cyclization method for Cefem skeletonInfo
- Publication number
- JPS609516B2 JPS609516B2 JP50028452A JP2845275A JPS609516B2 JP S609516 B2 JPS609516 B2 JP S609516B2 JP 50028452 A JP50028452 A JP 50028452A JP 2845275 A JP2845275 A JP 2845275A JP S609516 B2 JPS609516 B2 JP S609516B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- acid
- groups
- parts
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000007363 ring formation reaction Methods 0.000 title claims description 7
- 238000000034 method Methods 0.000 title claims description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 45
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 10
- 125000001118 alkylidene group Chemical class 0.000 claims description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 84
- -1 aralkanoyl Chemical group 0.000 description 68
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 48
- 238000006243 chemical reaction Methods 0.000 description 40
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 33
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 33
- 239000000243 solution Substances 0.000 description 33
- 238000003756 stirring Methods 0.000 description 31
- 239000002904 solvent Substances 0.000 description 29
- 125000001424 substituent group Chemical group 0.000 description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 24
- 239000002253 acid Substances 0.000 description 23
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 22
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 20
- 239000000203 mixture Substances 0.000 description 20
- 125000002252 acyl group Chemical group 0.000 description 19
- 229960000583 acetic acid Drugs 0.000 description 15
- 239000000047 product Substances 0.000 description 14
- 239000005457 ice water Substances 0.000 description 13
- 239000002994 raw material Substances 0.000 description 13
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 12
- QNXQLPUEZYZYFC-UHFFFAOYSA-N (4-nitrophenyl)methyl acetate Chemical compound CC(=O)OCC1=CC=C([N+]([O-])=O)C=C1 QNXQLPUEZYZYFC-UHFFFAOYSA-N 0.000 description 11
- 125000003396 thiol group Chemical group [H]S* 0.000 description 11
- 125000000217 alkyl group Chemical group 0.000 description 10
- 125000003277 amino group Chemical group 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 10
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 10
- 235000019341 magnesium sulphate Nutrition 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 238000005406 washing Methods 0.000 description 9
- 239000002585 base Substances 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 229910052736 halogen Inorganic materials 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- 125000006503 p-nitrobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1[N+]([O-])=O)C([H])([H])* 0.000 description 8
- SVDWECPQUANQNC-UHFFFAOYSA-N 2-(azetidin-1-yl)acetic acid Chemical class OC(=O)CN1CCC1 SVDWECPQUANQNC-UHFFFAOYSA-N 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 125000003118 aryl group Chemical group 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 150000002367 halogens Chemical class 0.000 description 7
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 7
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- 125000004354 sulfur functional group Chemical group 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 125000004423 acyloxy group Chemical group 0.000 description 6
- 125000001475 halogen functional group Chemical group 0.000 description 6
- 229960001866 silicon dioxide Drugs 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- 125000000453 2,2,2-trichloroethyl group Chemical group [H]C([H])(*)C(Cl)(Cl)Cl 0.000 description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 125000003710 aryl alkyl group Chemical group 0.000 description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 5
- 229910052794 bromium Inorganic materials 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- 125000004149 thio group Chemical group *S* 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 125000005035 acylthio group Chemical group 0.000 description 4
- 125000001931 aliphatic group Chemical group 0.000 description 4
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 150000007522 mineralic acids Chemical group 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 150000007524 organic acids Chemical group 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- XHAXVDWUMCHTCY-UHFFFAOYSA-N 2,2,2-trichloroethyl acetate Chemical compound CC(=O)OCC(Cl)(Cl)Cl XHAXVDWUMCHTCY-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 125000004442 acylamino group Chemical group 0.000 description 3
- 125000003545 alkoxy group Chemical group 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 125000003435 aroyl group Chemical group 0.000 description 3
- 125000001691 aryl alkyl amino group Chemical group 0.000 description 3
- 125000001769 aryl amino group Chemical group 0.000 description 3
- QBKMWJRMLACRJD-UHFFFAOYSA-N benzhydryl acetate Chemical compound C=1C=CC=CC=1C(OC(=O)C)C1=CC=CC=C1 QBKMWJRMLACRJD-UHFFFAOYSA-N 0.000 description 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
- 125000001589 carboacyl group Chemical group 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 125000002743 phosphorus functional group Chemical group 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- DBVJJBKOTRCVKF-UHFFFAOYSA-N Etidronic acid Chemical group OP(=O)(O)C(O)(C)P(O)(O)=O DBVJJBKOTRCVKF-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 125000005277 alkyl imino group Chemical group 0.000 description 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 125000004659 aryl alkyl thio group Chemical group 0.000 description 2
- 125000005110 aryl thio group Chemical group 0.000 description 2
- 125000004104 aryloxy group Chemical group 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000005587 carbonate group Chemical group 0.000 description 2
- 150000001782 cephems Chemical class 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000004020 conductor Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000004993 haloalkoxycarbonyl group Chemical group 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 230000002140 halogenating effect Effects 0.000 description 2
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 2
- 125000005638 hydrazono group Chemical group 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- 125000004043 oxo group Chemical group O=* 0.000 description 2
- 125000005499 phosphonyl group Chemical group 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 125000000464 thioxo group Chemical group S=* 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- YBADLXQNJCMBKR-UHFFFAOYSA-N (4-nitrophenyl)acetic acid Chemical compound OC(=O)CC1=CC=C([N+]([O-])=O)C=C1 YBADLXQNJCMBKR-UHFFFAOYSA-N 0.000 description 1
- WTZPXQAJILENBR-UUSAFJCLSA-N (4-nitrophenyl)methyl (6R)-3-hydroxy-7-[(2-hydroxyphenyl)methylideneamino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound C(C=1C(O)=CC=CC=1)=NC1[C@@H]2N(C(=C(CS2)O)C(=O)OCC2=CC=C(C=C2)[N+](=O)[O-])C1=O WTZPXQAJILENBR-UUSAFJCLSA-N 0.000 description 1
- MSJBRVIZZHKNPL-BDPMCISCSA-N (4-nitrophenyl)methyl (6r)-3-hydroxy-8-oxo-7-[(2-phenoxyacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound C1([C@@H]2N(C1=O)C(=C(CS2)O)C(=O)OCC=1C=CC(=CC=1)[N+]([O-])=O)NC(=O)COC1=CC=CC=C1 MSJBRVIZZHKNPL-BDPMCISCSA-N 0.000 description 1
- YTCUEIOOUOMPAT-RXMQYKEDSA-N (6r)-3-hydroxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound OC(=O)C1=C(O)CS[C@@H]2CC(=O)N12 YTCUEIOOUOMPAT-RXMQYKEDSA-N 0.000 description 1
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 description 1
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 241001609213 Carassius carassius Species 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 239000002879 Lewis base Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 1
- KFOMSQLCZUDRNJ-UHFFFAOYSA-N N(=[N+]=[N-])N=NN=NNNN Chemical compound N(=[N+]=[N-])N=NN=NNNN KFOMSQLCZUDRNJ-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 150000008043 acidic salts Chemical class 0.000 description 1
- 125000005041 acyloxyalkyl group Chemical group 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 125000000676 alkoxyimino group Chemical group 0.000 description 1
- 125000005138 alkoxysulfonyl group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 150000007860 aryl ester derivatives Chemical class 0.000 description 1
- 125000004467 aryl imino group Chemical group 0.000 description 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 150000001753 carvones Chemical class 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- QHTOIDKCEPKVCM-ZCFIWIBFSA-N cepham group Chemical group S1CCCN2[C@H]1CC2=O QHTOIDKCEPKVCM-ZCFIWIBFSA-N 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- UETQVDZZPKAQIC-UHFFFAOYSA-N chlorane Chemical compound Cl.Cl.Cl.Cl UETQVDZZPKAQIC-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229940117389 dichlorobenzene Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- LRCFXGAMWKDGLA-UHFFFAOYSA-N dioxosilane;hydrate Chemical compound O.O=[Si]=O LRCFXGAMWKDGLA-UHFFFAOYSA-N 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical group C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 125000004119 disulfanediyl group Chemical group *SS* 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012039 electrophile Substances 0.000 description 1
- HWJHWSBFPPPIPD-UHFFFAOYSA-N ethoxyethane;propan-2-one Chemical compound CC(C)=O.CCOCC HWJHWSBFPPPIPD-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000000268 heptanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 125000001261 isocyanato group Chemical group *N=C=O 0.000 description 1
- 125000002462 isocyano group Chemical group *[N+]#[C-] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 150000007527 lewis bases Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910000000 metal hydroxide Inorganic materials 0.000 description 1
- 150000004692 metal hydroxides Chemical class 0.000 description 1
- FBBDOOHMGLLEGJ-UHFFFAOYSA-N methane;hydrochloride Chemical compound C.Cl FBBDOOHMGLLEGJ-UHFFFAOYSA-N 0.000 description 1
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000006502 nitrobenzyl group Chemical group 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 125000000018 nitroso group Chemical group N(=O)* 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 150000003009 phosphonic acids Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002577 pseudohalo group Chemical group 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- DUIOPKIIICUYRZ-UHFFFAOYSA-N semicarbazide Chemical compound NNC(N)=O DUIOPKIIICUYRZ-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 229960004029 silicic acid Drugs 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 125000004646 sulfenyl group Chemical group S(*)* 0.000 description 1
- 150000003455 sulfinic acids Chemical class 0.000 description 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 125000002769 thiazolinyl group Chemical group 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 125000004665 trialkylsilyl group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
- C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】
この発明はQ〔(4ーメルカプトまたは置換チオ)−3
一(アミノまたは置換アミノ)‐2ーオキソアゼチジン
−1ーイル〕一Q−(2ーハロー1一層襖アルキリデン
または2ーハロー1一置換アルキル)酢酸またはそのカ
ルボキシ基における誘導体を濠化反応に付して7一(ア
ミノまたは置換アミ/)−3−置換−(セフェムまたは
セフアム)−4ーカルボン酸またはそのカルボキシ基に
おける誘導体を製造する方法に関する。DETAILED DESCRIPTION OF THE INVENTION This invention provides Q[(4-mercapto or substituted thio)-3
[1-(amino or substituted amino)-2-oxoazetidin-1-yl]-Q-(2-halo 1 monolayer alkylidene or 2-halo 1 monosubstituted alkyl) acetic acid or its derivative at the carboxy group is subjected to a moat reaction. 7-(amino or substituted ami/)-3-substituted-(cephem or cephaam)-4-carboxylic acid or its derivative at the carboxy group.
この発明の原料物質である前記アゼチジン酢酸譲導体に
おいて:4位の置換チオ基における置換基としては有機
または無機酸から誘導されたアシル基、アルキル基、ア
ラルキル基、アリール基ならびに脂肪族または芳香族の
メルカプト基など4位のメルカプト基の保護基であって
、望ましくは後に容易に除去できる基を例示することが
できる。In the azetidine acetic acid derivative, which is the raw material of this invention, the substituent on the substituted thio group at the 4-position is an acyl group, an alkyl group, an aralkyl group, an aryl group derived from an organic or inorganic acid, and an aliphatic or aromatic group. A protecting group for a mercapto group at the 4-position, such as a mercapto group, and preferably a group that can be easily removed later can be exemplified.
更に具体的にはアシル基〔炭酸アシル基(アルコキシカ
ルボニル、ハロアルコキシカルボニル、アラルコキシカ
ルボニルなど)、硫酸アシル基などの無機アシル基;ア
ルカノィル、アラルカノィル、アロイル、アルキルスル
ホニル、アリールスルホニルなどの有機アシル基〕、ア
ルキル基(メチル、エチルなど)、アラルキル基(ベン
ジル、ジフェニルメチル、トリチルなど)、アリール基
(フヱニル、チェニル、ピリジルなど)、脂肪族または
芳香族のメルカプト基(メチルチオ、エチルチオ、シク
ロプロピルメチルチオ、ベンジルチオ、ピリジルメチル
チオ、○ーニトロフエニルチオ、2ーメチルー1・3・
4ーチアジアゾール−5ーイルチオ、ベンゾチアゾール
ー2ーイルチオ、キノリンー2−イルチオ、アセチルチ
オなど)のほかにアミノ(プロピルアミノ、アニリノな
ど)その他の基を例示できる。これらの基はし、ずれも
可能な場合にはハロゲン、硫黄基、酸素基、窒素基、炭
素基その他の置換基を有していてもよく、また不飽和結
合を有していてもよい。特に炭酸アシル基、硫酸アシル
基、アラルキル基、脂肪族または芳香族のチオ基、アミ
ノ基など緩和な分解反応によりメルカプト基、チオ・ラ
ジカル、スルフェニル・アニオンなどを作り得る基は望
ましい。3位のアミノ基または置換アミノ基におけるア
ミノ置換基は天然または合成ペニシリンならびにセフア
ロスポリンの化学における公知の側鎖を構成するァミノ
置換基またはそれと均等なものも含むものとする。More specifically, acyl groups [inorganic acyl groups such as acyl carbonate groups (alkoxycarbonyl, haloalkoxycarbonyl, aralkoxycarbonyl, etc.), acyl sulfate groups; organic acyl groups such as alkanoyl, aralkanoyl, aroyl, alkylsulfonyl, arylsulfonyl, etc. ], alkyl groups (methyl, ethyl, etc.), aralkyl groups (benzyl, diphenylmethyl, trityl, etc.), aryl groups (fenyl, chenyl, pyridyl, etc.), aliphatic or aromatic mercapto groups (methylthio, ethylthio, cyclopropyl, etc.) Methylthio, benzylthio, pyridylmethylthio, ○nitrophenylthio, 2-methyl-1, 3,
In addition to 4-thiadiazol-5-ylthio, benzothiazol-2-ylthio, quinolin-2-ylthio, acetylthio, etc., amino (propylamino, anilino, etc.) and other groups can be exemplified. Any of these groups may have a halogen, sulfur group, oxygen group, nitrogen group, carbon group, or other substituent, and may also have an unsaturated bond. Particularly desirable are groups that can produce mercapto groups, thio radicals, sulfenyl anions, etc. through mild decomposition reactions, such as acyl carbonate groups, acyl sulfate groups, aralkyl groups, aliphatic or aromatic thio groups, and amino groups. The amino substituent in the amino group or substituted amino group at the 3-position is intended to include amino substituents or equivalents thereof constituting known side chains in the chemistry of natural or synthetic penicillins and cephalosporins.
この置換基は一般に4位メルカプト基とQ位側鎖におけ
る閉環反応とは直後関連がないので広範囲な変化が可能
である。代表的なァミノ置換基は炭化水素基(メチル、
プロピル、第三級ブチル、ベンジル、ベンズヒドリル、
トリチル、アルキリデン、ベンジリデン、o−オキシベ
ンジリデンなど)、シリル基(トリアルキルシリルなど
)、スルフェニル基(oーニトロフェニルスルフェニル
など)、アシル基〔炭酸アシル基(アルコキシカルボニ
ル、ハロアルコキシカルボニル、アラルコキシカルボニ
ノレ、アリールオキシカルボニルなど)、硫酸アシル基
、りん酸アシル基(ホスホニル、ジアルコキシホスホニ
ノレ、チオホスホニルなど)、その他の無機アシル基ま
たはアルカノィル、シクロアルカノイル、アラルカノイ
ル、アロイル、アルキルスルホニル、アリールスルホニ
ル、アルキルホスホニル、その他の有機アシル基〕など
のァミノ置換基であって可能な場合にはハロゲン、硫黄
基、酸素基、窒素基、炭素基、その他の置換基を有して
いてもよくまた不飽和結合を有していてもよい。Since this substituent is generally not directly related to the mercapto group at the 4-position and the ring-closing reaction at the side chain at the Q-position, a wide range of changes is possible. Typical amino substituents are hydrocarbon groups (methyl,
Propyl, tertiary butyl, benzyl, benzhydryl,
trityl, alkylidene, benzylidene, o-oxybenzylidene, etc.), silyl group (trialkylsilyl, etc.), sulfenyl group (o-nitrophenylsulfenyl, etc.), acyl group [carbonate acyl group (alkoxycarbonyl, haloalkoxycarbonyl, aral oxycarbonyl, aryloxycarbonyl, etc.), acyl sulfate groups, acyl phosphate groups (phosphonyl, dialkoxyphosphonyl, thiophosphonyl, etc.), other inorganic acyl groups or alkanoyl, cycloalkanoyl, aralkanoyl, aroyl, alkylsulfonyl, aryl Amino substituents such as sulfonyl, alkylphosphonyl, and other organic acyl groups], which may have halogens, sulfur groups, oxygen groups, nitrogen groups, carbon groups, and other substituents, if possible. It may also have an unsaturated bond.
またアジド、ィソシアトナト、ィソシアノ基などアミノ
またはァミド基に変換できる基も置換ァミノ基の定義に
含めるものとする。アミノ置換基の中でも、特に天然の
べニシljンにおける側鎖に含まれるアシル基(フェノ
キシアセチル、フエニルアセチル、ヘプタノイルなど)
および容易に除去し得る置換基(トリチル、ベンジリデ
ン、フタロイル、アリールスルフエニル、トリメチルシ
リル、2・2・2−トリクロロエトキシカルボニル、ベ
ンジルオキシカルボニル、フエノキシアセチル、フヱニ
ルアセチルなど)、目的化合物に有利な作用をもたらす
基に容易に変形し得る基(N−第三級ブトキシ−Q−フ
ェニルグリシル、Q一(3ーカルベトキシー2ープoベ
ンー2ーイルアミノ)ーフエニルアセチル、Qーアジド
フェニルアセチルなど)は製造上重要である。Groups that can be converted into amino or amide groups, such as azide, isocyanato, and isocyano groups, are also included in the definition of substituted amino groups. Among amino substituents, acyl groups (phenoxyacetyl, phenylacetyl, heptanoyl, etc.) contained in the side chain of natural benicylj, in particular
and easily removable substituents (trityl, benzylidene, phthaloyl, arylsulfenyl, trimethylsilyl, 2,2,2-trichloroethoxycarbonyl, benzyloxycarbonyl, phenoxyacetyl, phenylacetyl, etc.), which are advantageous for the target compound. Groups that can be easily transformed into functional groups (N-tert-butoxy-Q-phenylglycyl, Q-(3-carbetoxy-2-ben-2-ylamino)-phenylacetyl, Q-azidophenylacetyl, etc.) is important in manufacturing.
置換アミノ基が環状基を形成して例えば4−オキソ−3
−ィミダゾリジニル基などとなっていてもよい。反応性
置換基は公知の方法で保護しておくことができる。これ
らの基は生成物であるセフェム化合物においては7位の
置換基に相当するが反応条件下で一部変化を受ける場合
もある。3位のアミノ基と4位のアシルチオ基がアシル
基を共有した形の化合物である3−置換−4−チアー2
16ージアザ−7ーオキソピシクロ〔3・210〕へプ
ト−2ーェン−6−ィル酢酸なども前記Q−(4−アシ
ルチオ−3−アミノ−2ーオキソアゼチジンー1−イル
)−Q−(置換または非置換)酢酸の定義の範囲内に含
めるものとする。Substituted amino groups form a cyclic group, e.g. 4-oxo-3
-imidazolidinyl group, etc. Reactive substituents can be protected by known methods. These groups correspond to the substituents at the 7-position in the product cephem compound, but may undergo partial changes under the reaction conditions. 3-substituted-4-thia2, which is a compound in which the amino group at the 3-position and the acylthio group at the 4-position share an acyl group
16-diaza-7-oxopicyclo[3.210]hept-2-en-6-yl acetic acid and the like are also substituted with the above Q-(4-acylthio-3-amino-2-oxoazetidin-1-yl)-Q- or unsubstituted) shall be included within the definition of acetic acid.
また3位のアミノ基は酸(有機酸または無機酸)と塩を
形成してもよい。前記アゼチジン酢酸のカルボキシ基に
おける誘導体としてはェステル〔アルキルェステル(メ
チル、エチル、トリクロロエチルーエステルなど)アラ
ルキルエステル(ベンジル、メトキシベンジル、ニトロ
ベンジル、ジフエニルメチル、トリチルーエステルなど
)、アリールエステル(フエニル、ナフチルーェステル
など)、金属ェステル(トリメチルシリル、トリ〆チル
すず−エステルなど)、その他のェステル、酸無水物、
塩(ナトリウム、カリウム、マグネシウム、アルミニウ
ム−塩など)、チオールェステル、アミド、ヒドラジド
、アジドなどのカルボキシ誘導体である。Further, the amino group at the 3-position may form a salt with an acid (organic acid or inorganic acid). Derivatives of the carboxy group of azetidine acetic acid include esters [alkyl esters (methyl, ethyl, trichloroethyl ester, etc.), aralkyl esters (benzyl, methoxybenzyl, nitrobenzyl, diphenylmethyl, trityl ester, etc.), aryl esters (phenyl, naphthyl ester, etc.), metal esters (trimethylsilyl, trityltin ester, etc.), other esters, acid anhydrides,
carboxy derivatives such as salts (sodium, potassium, magnesium, aluminum salts, etc.), thiolesters, amides, hydrazides, azides, etc.
これらのカルボキシ誘導体の部分には、可能な場合には
前記のようなハロゲン、硫黄基、酸素基、窒素基、炭素
基その他の置換基を有していてもよくまた不飽和結合を
有していてもよい。これらのカルボキシ議導体のうち、
反応に対して不活性であって、反応後に分子中の他の部
分に不都合な変化を起さずに除去できる基(ハ。If possible, these carboxy derivatives may have substituents such as halogen, sulfur group, oxygen group, nitrogen group, carbon group, and other substituents, and may also have unsaturated bonds. It's okay. Among these carboxylic conductors,
Groups that are inert to the reaction and can be removed after the reaction without causing any unfavorable changes in other parts of the molecule (iii).
アルキルーアシルアルキル、アルコキシアルキル、アシ
ルオキシアルキル、アラルキルーエステルなど、ジアル
キルヒドラジド、アルカリ金属塩、アルキルアミン塩な
ど)を含む誘導体は重要である。前記ァゼチジンー1一
酢酸のQ位における置換基である2ーハロ−1一置換ア
ルキリデン基の1位置換基はハロゲン(塩素、臭素、よ
う素など)、酸素基〔ヒドロキシ、アシルオキシ(アル
カン酸、アルゲン酸、アルキル酸、シクロアルカン酸、
アラルカン酸、アラルケン酸、芳香族カルボン酸などの
カルポン酸、スルホン酸、スルフィン酸、ホスホン酸な
どの有機酸から誘導されたアシル基または炭酸、硫酸、
りん酸、ハロゲン酸などの無機酸から誘導されたアシル
基を有するアシルオキシ基)、アルコキシ基(メトキシ
、ヱトキシ、ィソプロピルオキシ、第三級ブトキシなど
)、アラルコキシ(ベンジルオキシ、ベンズヒドリルオ
キシ、トリチルオキシなど)、アリールオキシ(フェノ
キシ、ピリジルオキシなど)〕、硫黄基〔メルカプト、
アシルチオ(アシルオキシの項に述べたアシル基を有す
るアシルチオ基)、アルキルチオ基(メチルチオ、エチ
ルチオなど)、アラルキルチオ(ベンジルチオなど)、
アリールチオ(フェニルチオ、ナフチルチオなど)〕、
窒素基〔ァミノ、アシルアミノ(ァシルオキシ基の項に
述べたアシル基を1なし、し2個有するアシルァミ/基
)、アルキルアミノ(メチルアミ/、ジェチルアミノ、
ピベリジンー1−イル、モルホリン−4ーイルなど)、
アルキルアシルアミノ(メチルアセチルアミノなど)、
アラルキルアミノ、アリールアミノ、ヒドラジド、セミ
カルバジド、ヒドロキシルアミノ、アルコキシアミ/、
アラルキルアミノ、アリールアミノなど〕、りん基(ジ
フェニルホスフィニルなど)、その他の1価の置換基で
ある。Of interest are derivatives containing alkyl-acylalkyl, alkoxyalkyl, acyloxyalkyl, aralkyl-esters, dialkyl hydrazides, alkali metal salts, alkylamine salts, etc.). The 1-position substituent of the 2-halo-1-monosubstituted alkylidene group, which is the substituent at the Q-position of azetidine-1-monoacetic acid, is a halogen (chlorine, bromine, iodine, etc.), oxygen group [hydroxy, acyloxy (alkanoic acid, algenic acid, etc.)]. , alkyl acids, cycloalkanoic acids,
Acyl groups derived from carboxyl acids such as aralkanoic acid, aralkenic acid, aromatic carboxylic acids, organic acids such as sulfonic acids, sulfinic acids, and phosphonic acids, or carbonic acid, sulfuric acid,
Acyloxy groups (having acyl groups derived from inorganic acids such as phosphoric acid and halogen acids), alkoxy groups (methoxy, ethoxy, isopropyloxy, tertiary butoxy, etc.), aralkoxy (benzyloxy, benzhydryloxy, (trityloxy, etc.), aryloxy (phenoxy, pyridyloxy, etc.)], sulfur group (mercapto,
Acylthio (acylthio group having an acyl group as described in the acyloxy section), alkylthio group (methylthio, ethylthio, etc.), aralkylthio (benzylthio, etc.),
Arylthio (phenylthio, naphthylthio, etc.)
Nitrogen group [amino, acylamino (acylamino/group having one or two acyl groups mentioned in the section of acyloxy group), alkylamino (methylamino/, jetylamino,
piberidin-1-yl, morpholin-4-yl, etc.),
Alkylacylamino (such as methylacetylamino),
Aralkylamino, arylamino, hydrazide, semicarbazide, hydroxylamino, alkoxylamino/,
aralkylamino, arylamino, etc.], phosphorus groups (diphenylphosphinyl, etc.), and other monovalent substituents.
前記ァゼチジンー1−酢酸のQ位における置換基である
2ーハo−1一置換アルキル基の1位置換基は前記2−
ハロー1−置換ァルキ1」デン基における置換基と同じ
もの2個、あるいはオキソ、チオキソ、イミノ、アルキ
ルイミノ、ヒドロキシイミノ、アルコキシイミノ、アシ
ルオキシイミノ、アラルコキシイミノ、アリールイミノ
、ヒドラゾノ、アシルヒドラゾノ、アルキルヒドラゾノ
、アリールヒドラゾノなど2価の酸素基、硫黄基、窒素
基、りん基などの置換基である。The 1-position substituent of the 2-ha o-1 monosubstituted alkyl group, which is the substituent at the Q-position of the azetidine-1-acetic acid, is the 2-
2 of the same substituents as in the halo 1-substituted alkyl 1"dene group, or oxo, thioxo, imino, alkylimino, hydroxyimino, alkoxyimino, acyloxyimino, aralkoxyimino, arylimino, hydrazono, acylhydrazono, alkyl Substituents include divalent oxygen groups such as hydrazono and arylhydrazono, sulfur groups, nitrogen groups, and phosphorus groups.
これらのァゼチジンー1一酢酸のQ位における置換基で
ある1一層襖アルキリデンまたは1一置換ァルキル基な
らびにこれらの1位置換基には可能な場合にはハロゲン
、酸素基、硫黄基、窒素基、炭素基その他の置換基を有
していてもよく、また不飽和結合を有していてもよい。The substituent at the Q position of these azetidine-1 monoacetic acids, 1 monolayer alkylidene or 1 monosubstituted alkyl group, and these 1-position substituents, if possible, include halogen, oxygen group, sulfur group, nitrogen group, carbon It may have a group or other substituent, and it may also have an unsaturated bond.
前記ァゼチジン−1−酢酸のQ位における置換基である
2−ハロー1−置換ァルキリデン基または2−ハロー1
−置換ァルキル基における2位のハロゲンは塩基、臭素
、よう素およびこれと均等な機能を有するシュード・ハ
ロゲンまたは脱離基と総称される一群の基(スルホニル
オキシ、アルカノイルオキシ、ベンゾイルオキシ、ヒド
ロキシなど)もこの定義の範囲内に含めるものとする。
前記各基中に有し得る置換基はハロゲン(ふっ素、塩素
、臭素など)、硫黄基(メルカプト、ァルキルチオ、ア
ララルキルチオ、アリールチオ、アシルチオ、チオキソ
、スルホ、スルホニル、スルフイニル、アルコキシスル
ホニル、アリールオキシスルフィニルなど)、酸素基(
ヒドロキシ、アルコキシ、アラルコキシ、アリールオキ
シ、アシルオキシ、オキソなど)、窒素基(アミノ、ヒ
ドラゾ、ジアゾ、アジド、アルキルアミノ、アラルキル
アミノ、アリールアミノ、アシルアミノ、アルキリデン
アミノ、アシルイミノ、イミノ、アルキルィミノ、ニト
ロソ、ニトロなど)、炭素基(アルキル、アルケニル、
アラルキル、芳香族異頃環基を含むアリール、カルボキ
シ、カルバモィル、力ルボアルコキシ、アルカノイル、
アラルカノィル、アロィル、シアノなど)などの他に、
りん基(ホスホニルなど)、その他の置換基を含むもの
とする。前記反応の原料物質であるQ−〔4一層襖チオ
ー3一(アミノまたは置換アミ/)−2−オキソアゼチ
ジン−1ーイル〕一Q−(2−ハロー1−置換アルキリ
デンまたは2ーハロ−1一置換アルキル)酢酸またはそ
のカルボキシ基における誘導体は、例えばペニシリン・
1−オキシドを亜りん酸ェステル、無水酢酸などで分解
してQ−(アゼチジン−1ーィル)−Q−(ィソフ。2-halo 1-substituted alkylidene group or 2-halo 1 which is a substituent at the Q position of the azetidine-1-acetic acid
- The halogen at the 2-position in the substituted alkyl group is a base, bromine, iodine, and a group of groups collectively called pseudohalogens or leaving groups (sulfonyloxy, alkanoyloxy, benzoyloxy, hydroxy, etc.) that have equivalent functions. ) shall also be included within the scope of this definition.
The substituents that each of the above groups may have include halogen (fluorine, chlorine, bromine, etc.), sulfur group (mercapto, alkylthio, aralkylthio, arylthio, acylthio, thioxo, sulfo, sulfonyl, sulfinyl, alkoxysulfonyl, aryloxysulfinyl, etc.) , oxygen group (
hydroxy, alkoxy, aralkoxy, aryloxy, acyloxy, oxo, etc.), nitrogen groups (amino, hydrazo, diazo, azide, alkylamino, aralkylamino, arylamino, acylamino, alkylidene amino, acylimino, imino, alkylimino, nitroso, nitro, etc.) ), carbon groups (alkyl, alkenyl,
aralkyl, aryl containing aromatic heterocyclic groups, carboxy, carbamoyl, alkyloxy, alkanoyl,
In addition to aralcanol, aroyl, cyano, etc.),
It shall include a phosphorus group (such as phosphonyl) and other substituents. The starting material for the reaction is Q-[4 monolayer thiol 3-(amino or substituted amino/)-2-oxoazetidin-1-yl]-Q-(2-halo 1-substituted alkylidene or 2-halo-1 monosubstituted alkyl) ) acetic acid or its derivatives at the carboxy group, such as penicillin.
1-oxide is decomposed with phosphite, acetic anhydride, etc. to produce Q-(azetidin-1-yl)-Q-(isoph).
ロベニル)酢酸誘導体とし、これをオゾンで酸化すれば
Q位の置換基が1−ヒドロキシェチリデンまたは1−ア
セチルである原料物質が得られ、要すればこれにハロゲ
ン化剤、エーテル化剤、アシル化剤、アミノ化剤、チオ
ェーテル化剤、活性窒素化剤などを作用させて1位の置
換基を変換したのちに、ハロゲン化剤などを作用させれ
ば合成できる。本発明の方法を実施するには、前記原料
物質を閉環反応に付す。By oxidizing this with ozone, a raw material in which the substituent at the Q position is 1-hydroxyethylidene or 1-acetyl is obtained, and if necessary, a halogenating agent, an etherifying agent, Synthesis can be achieved by converting the substituent at the 1-position using an acylating agent, aminating agent, thioetherizing agent, active nitrogenating agent, etc., and then reacting with a halogenating agent. To carry out the method of the invention, the raw material is subjected to a ring-closing reaction.
閉環反応は、例えば塩基性、中性、酸性のいずれの条件
下でも、また接触剤の存在下に均一相または異相反応に
よっても起り、原料物質の構造により、条件は適宜選択
できる。原料物質としてはアゼチジン−1一酢酸の4位
のチオ基がメルカプト基またはメルカプチド。アニオン
であるものが反応性が高く、好ましい。したがって要す
れば置換チオ基は、あらかじめ保護基を除去してメルカ
プトまたはメルカプチド基としてから反応するか、ある
いは保護基の除去される反応条件下で閉環反応を行うこ
とが好ましいことがある。また、原料物質がチァゾリノ
アゼチジン骨格を有する場合には、チアゾリン環の関環
する条件下に、緩和に関環反応が進行し、高収率で目的
物質を得ることができる。酸性とするために用いる酸と
しては鉱酸(塩酸、臭化水素酸、硫酸、硝酸、りん酸「
過塩素酸「亜硫酸など)、スルホン酸(アルカンスルホ
ン酸、アリールスルホン酸など)、ホスホン酸「カルボ
ン酸(ぎ酸、酢酸、ハロアルカン酸、しゆう酸、フタル
酸など)、その他の有機または無機酸、あるいはそれら
と弱塩基(芳香族または脂肪族の塩基、アンモニア、ア
ルカリ士類金属、アルミニウム、銀など)との塩、ある
いは前記酸と一般の塩基との酸性塩が用いられる。The ring-closing reaction occurs, for example, under basic, neutral, or acidic conditions, or by homogeneous phase or heterophase reaction in the presence of a contact agent, and the conditions can be appropriately selected depending on the structure of the raw material. As a raw material, the thio group at the 4-position of azetidine-1 monoacetic acid is a mercapto group or mercaptide. Anions are preferable because they have high reactivity. Therefore, if necessary, it may be preferable to first remove the protecting group from the substituted thio group to form a mercapto or mercaptide group before reacting, or to carry out the ring-closing reaction under reaction conditions in which the protecting group is removed. Further, when the raw material has a thiazolinoazetidine skeleton, the ring reaction proceeds slowly under conditions where the thiazoline ring is linked, and the target substance can be obtained in high yield. The acids used to make it acidic include mineral acids (hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, phosphoric acid).
Perchloric acid (sulfurous acid, etc.), sulfonic acid (alkanesulfonic acid, arylsulfonic acid, etc.), phosphonic acid, carboxylic acid (formic acid, acetic acid, haloalkanoic acid, oxalic acid, phthalic acid, etc.), other organic or inorganic acids or salts of these with weak bases (aromatic or aliphatic bases, ammonia, alkali metals, aluminum, silver, etc.), or acidic salts of the above acids with general bases.
また、ルイス酸もプロトン不含溶媒中で有利に用いられ
る。塩基性とするために用いる塩基としては前記のよう
な弱塩基が好ましい。強塩基(ァルカIJ金属水酸化物
、アルカリ金属炭酸塩、第4級アンモニウム水酸化物な
ど)は原料物質または生成物の分子の一部、特に8ーラ
クタム環などを、分解するので、その使用に当っては弱
い条件を選択する必要がある。また、ルイス塩基も用い
ることができる。接触剤としては中性ないし塩基性のシ
リカゲル、アルミナ、桂藻士、フロリジル、その他の接
触剤を用いることができる。Lewis acids are also advantageously used in proton-free solvents. The base used for basicity is preferably a weak base as described above. Strong bases (Arka IJ metal hydroxides, alkali metal carbonates, quaternary ammonium hydroxides, etc.) decompose part of the molecules of the raw material or product, especially the 8-lactam ring, and should not be used. If this happens, you need to choose a weaker condition. Additionally, Lewis bases can also be used. As the contact agent, neutral or basic silica gel, alumina, Keishoshi, Florisil, and other contact agents can be used.
場合によっては溶媒(ヘキサメチルホスホロトリアミド
、ジメチルホルムアミド、アルコール、水など)のみで
も反応が進行する。In some cases, the reaction proceeds even with only a solvent (hexamethylphosphorotriamide, dimethylformamide, alcohol, water, etc.).
この場合、水、アルコールなど適性溶媒が存在すると反
応速度が大きくなる。この場合には反応によって生成す
るハロゲン化水素が反応促進剤として作用しているとも
考えられる。原料物質がチアゾリノアゼチジンの場合に
は、付加関環反応が必要なので、水、アルコール、水素
イオンを出し得る酸、アミンなどの求核試薬、酸無水物
、酸ハロゲン化物などの求電子試薬、その他の付加剤1
当量以上が存在することが好ましい。In this case, the reaction rate increases if a suitable solvent such as water or alcohol is present. In this case, it is thought that the hydrogen halide produced by the reaction acts as a reaction accelerator. When the raw material is thiazolinoazetidine, a ring addition reaction is required, so water, alcohol, acids that can release hydrogen ions, nucleophiles such as amines, electrophiles such as acid anhydrides, acid halides, etc. Reagents and other additives 1
Preferably, an equivalent or more is present.
置換チオ基をメルカプトまたはメルカプチド基とするに
は贋換基に応じてそれぞれ適当な試薬を作用させる。In order to convert the substituted thio group into a mercapto or mercaptide group, a suitable reagent is used depending on the substituted group.
この反応は好ましくは溶媒中、加熱下、室温または冷却
下に行なう。This reaction is preferably carried out in a solvent, under heat, at room temperature or under cooling.
要すれば不活性気体の存在下に、かきまぜながら反応で
きる。反応溶媒としては炭化水素(ベンタン、ヘキサン
、ベンゼン、トルェンなど)、ハロゲン化炭化水素(塩
化メチレン、クロロホルム、四塩化炭素、ジクロロベン
ゼンなど)、ェステル(酢酸エチル、酢酸ブチル、安息
香酸メチルなど)、ケトン(アセトン、シクロヘキサノ
ン、ベンゾフエノンなど)、エーテル(ジエチルエーテ
ル、エチレングリコール、ジメチルエーテル、テトラヒ
ドロフラン、テトラヒドロピラン、ジオキサン、モルホ
リン、アニソールなど)、アルコール(メタノール、エ
タノ−ル、エチレングリコール、ベンジルアルコールな
ど)、カルボン酸(酢酸、プロピオン酸など)、塩基(
ブチルアミン、トリヱチルアミン、ピリジン、ピコリン
など)、アミド(ジメチルホルムアミド、ジメチルアセ
トアミド、ヘキサメチルホスホロトリアミドなど)、ニ
トリル(アセトニトリル、ベンゾニトリルなど)、ニト
ロ炭化水素、スルホキシド(ジメチルスルホキシドなど
)、水、液体アンモニアなどおよびそれらの混合物が用
いられる。If necessary, the reaction can be carried out with stirring in the presence of an inert gas. Reaction solvents include hydrocarbons (bentane, hexane, benzene, toluene, etc.), halogenated hydrocarbons (methylene chloride, chloroform, carbon tetrachloride, dichlorobenzene, etc.), esters (ethyl acetate, butyl acetate, methyl benzoate, etc.), Ketones (acetone, cyclohexanone, benzophenone, etc.), ethers (diethyl ether, ethylene glycol, dimethyl ether, tetrahydrofuran, tetrahydropyran, dioxane, morpholine, anisole, etc.), alcohols (methanol, ethanol, ethylene glycol, benzyl alcohol, etc.), carvone Acids (acetic acid, propionic acid, etc.), bases (
butylamine, triethylamine, pyridine, picoline, etc.), amides (dimethylformamide, dimethylacetamide, hexamethylphosphorotriamide, etc.), nitriles (acetonitrile, benzonitrile, etc.), nitrohydrocarbons, sulfoxides (dimethylsulfoxide, etc.), water, liquid ammonia etc. and mixtures thereof are used.
特に極性の高いアルコール、カルボン酸、アミド、ニト
リル、ニトロ炭化水素、スルホキシド、水などの溶媒が
好ましく、原料物質を溶解する能力の高いェステル、エ
ーテル、ハロゲン化炭化水素などを共存させると反応が
容易になる場合がある。In particular, highly polar solvents such as alcohols, carboxylic acids, amides, nitriles, nitrohydrocarbons, sulfoxides, and water are preferred, and the reaction is facilitated by coexisting with esters, ethers, halogenated hydrocarbons, etc. that have a high ability to dissolve raw materials. It may become.
反応は通常、室温でも比較的速く進行し、好収率で目的
とするセフェムまたはセフアム化合物を得ることができ
る。反応生成物は反応液から常法により禾反応物、副生
成物、溶媒などを除去して単離したのち、再結晶、クロ
マトグラフィー、再沈澱など常法によつて精製すれば得
ることができる。The reaction usually proceeds relatively quickly even at room temperature, and the desired cephem or cephalic compound can be obtained in good yield. The reaction product can be obtained by removing and isolating reactants, by-products, solvents, etc. from the reaction solution using conventional methods, and then purifying it using conventional methods such as recrystallization, chromatography, reprecipitation, etc. .
反応生成物は2位には水素またはアルキル基が;7位に
は原料であるアゼチジンー1−酢酸誘導体の3位のアミ
ノ基または置換アミノ基が;3位には原料であるアゼチ
ジンー1−酢酸誘導体のQ位に置換している2−ハロー
1一置換ァルキリデンまたは2ーハロ−1一置換ァルキ
ル基における1位置換基が;それぞれ置換してセフェム
ー4−カルボン酸、セフアムー4ーカルボン酸またはそ
れらのカルボキシ基における譲導体である。The reaction product has a hydrogen or alkyl group at the 2-position; an amino group or a substituted amino group at the 3-position of the azetidine-1-acetic acid derivative, which is the raw material, at the 7-position; and the azetidine-1-acetic acid derivative, which is the raw material, at the 3-position. The 1-position substituent in the 2-halo-1 monosubstituted alkylidene or 2-halo-1 monosubstituted alkyl group substituted at the Q position of It is a conductor in
ただし、反応処理中に3位、7位等の置換基が変化を受
けて、原料と生成物の対応する置換基が同一でない場合
がある。所望の場合には適当な手段により原料と対応す
る置換基その他の置換基に変更することができる。この
ような場合もこの発明の範囲内に含めるものとする。生
成物のセフアム骨格において3位の炭素原子には二重結
合が存在するが、反応条件、処理条件により、二重結合
が2位、4位または置換基のいずれかに向っているもの
、あるいはそれらの混合物が得られる。However, substituents at the 3-position, 7-position, etc. undergo changes during the reaction treatment, and the corresponding substituents of the raw material and the product may not be the same. If desired, substituents corresponding to those of the raw materials or other substituents can be changed by appropriate means. Such cases shall also be included within the scope of this invention. A double bond exists in the carbon atom at the 3rd position in the Cepham skeleton of the product, but depending on the reaction conditions and processing conditions, the double bond is directed to the 2nd or 4th position or to a substituent, or A mixture thereof is obtained.
いずれの場合も本発明の生成物の定義内に含めるものと
する。7一(アミ/または置換ァミノ)−3一置換(セ
フェムまたはセフアム)−4ーカルポン酸またはそのカ
ルボキシ基における誘導体は抗菌作用を有し、医薬とし
て有用であるほか、他の有用な抗菌剤の合成中間体とし
て利用することができる。Any case shall be included within the definition of the product of the invention. 7 Mono(amino/or substituted amino)-3 monosubstituted (cephem or cephaam)-4-carboxylic acids or their derivatives at the carboxy group have antibacterial activity and are useful as medicines, as well as for the synthesis of other useful antibacterial agents. It can be used as an intermediate.
以下に実施例を示して本発明実施の態様を説明する。Examples are shown below to explain embodiments of the present invention.
生成物の物性は第1表に表示した。3位二重結合につい
ての命名上の記載は同時に他の位置異性体も含むものと
する。The physical properties of the product are shown in Table 1. The nomenclature regarding the 3-position double bond is intended to include other positional isomers as well.
例1
‘1} Q−(4ーシクロプロピルメトキシカルボニル
チオー3−フタルイミドー2−オキソアゼチジンー1ー
イル)−Q一(2−ブロモ−1ーシクロプロピルメトキ
シカルボニルオキシエチリデン)酢酸メチル500mg
を塩化メチレン20泌にとかし、塩化アルミニウム51
0mpを一度に加えて室温にてかきまぜる。Example 1 '1} Q-(4-cyclopropylmethoxycarbonylthio-3-phthalimido-2-oxoazetidin-1-yl)-Q-(2-bromo-1-cyclopropylmethoxycarbonyloxyethylidene) methyl acetate 500 mg
was dissolved in 20 parts of methylene chloride, and 51 parts of aluminum chloride was dissolved.
Add 0mp all at once and stir at room temperature.
1時間後、冷3%塩酸20の‘に注ぎ、塩化メチレンで
抽出する。After 1 hour, pour into 20' of cold 3% hydrochloric acid and extract with methylene chloride.
抽出液を水洗、硫酸マグネシウム上乾燥後、溶媒留去す
ればQ一(4−メルカプトー3−フタルイミド−2ーオ
キソアゼチジンー1ーイル)−Q−(2−フロモ−1一
ヒドロキシェチリデン)酢酸メチル252の9を得る。
収率:72.5%。IR:〃窓樹そ1790、1783
、1728、1670・1620伽−10NMR:6C
DCと31.8M(11HZ)IH、3,87s祖、4
.22十4,5MBq(10HZ)が、5.3紅d(1
1;5HZ)IH、5,7の(5HZ)IH、7,7胤
4日、12.SI日。■ Q−(4−メルカプトー3−
フタルイミド−2−オキソアゼジン−1−イル)一o一
(2−フロモ−1一ヒドロキシェチリデン)酢酸メチル
【a)を次の条件で反応させれば3ーヒドロキシー7ー
フタルイミドー3ーセフエムー4山力ルボン酸メチル【
b}を得る。After washing the extract with water and drying over magnesium sulfate, the solvent is distilled off to give Q-(4-mercapto-3-phthalimido-2-oxoazetidin-1-yl)-Q-(2-furomo-1-hydroxyethylidene). 9 of methyl acetate 252 is obtained.
Yield: 72.5%. IR:〃Madokiso 1790, 1783
, 1728, 1670・1620ka-10NMR:6C
DC and 31.8M (11HZ) IH, 3,87s ancestor, 4
.. 2214.5MBq (10HZ) is 5.3Kd (1
1;5HZ) IH, 5,7 (5HZ)IH, 7,7 seed 4 days, 12. SI day. ■ Q-(4-mercapto 3-
If methyl phthalimide-2-oxoazedin-1-yl)-(2-furo-1-hydroxyethylidene) acetate [a) is reacted under the following conditions, it will produce 3-hydroxy-7-phthalimido-3-cephemu-4-sankirubonic acid. Methyl [
b} is obtained.
(i)(aー80柵をベンゼン8の【にとかし、N・N
−ジメチルアニリン20の9を加えて窒素気流中還流す
る。(i) (a-80 comb the fence with benzene 8 [N・N
- Add 9 parts of 20 parts of dimethylaniline and reflux in a nitrogen stream.
3び分後、反応液を冷却し、5%塩酸を加えて酢酸エチ
ルで抽出する。After 3 minutes, the reaction solution was cooled, 5% hydrochloric acid was added, and the mixture was extracted with ethyl acetate.
抽出液を水洗し、硫酸マグネシウム上乾燥後、溶媒蟹去
する。残留物71の9に酢酸エチル1の‘を加えて放置
すれば【b}25のタカミ析出する。mp223〜22
6℃。収率:38.9%。(ii〕 ta}150の9
をへキサメチルホスホロトリアミド1の‘にとかし、室
温にて1時間かきまぜる。The extract is washed with water, dried over magnesium sulfate, and the solvent is removed. When 1 part of ethyl acetate is added to the residue 71 part of 9 and left to stand, [b}25 is precipitated. mp223-22
6℃. Yield: 38.9%. (ii) ta}9 of 150
Dissolve 1 part of hexamethylphosphorotriamide and stir at room temperature for 1 hour.
反応液に氷水6の上とエーテル0.5の‘とを加えて析
出する結晶を涙取すれば‘bー50の9を得る。収率:
40.8%。(iii)‘a}200の9をメルク社製
プレコーテッドPLC板(シリカゲルF−254)にス
ポットし、ベンゼン+酢酸エチル(2:1)混液で展開
する。Add 6 parts of ice water and 0.5 parts of ether to the reaction solution and remove the precipitated crystals to obtain 9 of 'b-50. yield:
40.8%. (iii) 'a} 9 of 200 was spotted on a pre-coated PLC plate (silica gel F-254) manufactured by Merck & Co., and developed with a mixture of benzene and ethyl acetate (2:1).
主生成物帯を3%メタノール含有酢酸エチルで抽出し、
抽出液を減圧下に濃縮乾固し、残留物をクロロホルムに
とかして不溶物を除き、クロロホルムを蟹去すれば‘b
}62の9を得る。The main product zone was extracted with ethyl acetate containing 3% methanol,
The extract was concentrated to dryness under reduced pressure, the residue was dissolved in chloroform to remove insoluble materials, and the chloroform was removed.
}Get 9 of 62.
収率:37.9%。このようにして製造した3−オキソ
ー7−フタルイミドセフアム一4ーカルボン酸メチル(
bーをジオキサンにとかし、ジアゾメタンのエーテル溶
液を加え、室温で1時間かきまぜる。Yield: 37.9%. Methyl 3-oxo-7-phthalimidocephalic acid 4-carboxylate (
Dissolve b- in dioxane, add an ethereal solution of diazomethane, and stir at room temperature for 1 hour.
反応液を減圧濃縮すれば3ーメトキシー7ーフタルィミ
ド−3ーセフェムー4−カルボン酸メチルを定量的に得
る。ァセトン十エーテル混液から再結晶すれば純結晶を
得る。mp225〜227C。例2
‘1) Q−(4ーシクロプロピルメトキシカルボニル
チオ−3−フヱノキシアセトアミドー2−オキソアゼチ
ジンー1ーイルーQ一〔2ーブロモ−1−(ピベリジン
ー1ーイル)エチリデン〕酢酸212・2ートリクロロ
ェチル573の9をメタノール30の‘にとかし10%
塩酸7泌を加えて、室温または40〜45qoでかきま
ぜる。By concentrating the reaction solution under reduced pressure, methyl 3-methoxy-7-phthalimido-3-cephemu-4-carboxylate is quantitatively obtained. Pure crystals can be obtained by recrystallization from acetone-ether mixture. mp225-227C. Example 2 '1) Q-(4-cyclopropylmethoxycarbonylthio-3-phenoxyacetamide 2-oxoazetidin-1-yl-Q-[2-bromo-1-(piveridin-1-yl)ethylidene]acetic acid 212. Dissolve 573 parts 9 of 2-trichloroethyl in 30 parts methanol to make 10%
Add 7-chloride of hydrochloric acid and stir at room temperature or 40-45 qo.
30分後、反応液を氷水に注ぎ、ベンゼンで抽出する。After 30 minutes, the reaction solution was poured into ice water and extracted with benzene.
抽出液を水洗、乾燥後、溶媒留去すればQ−(4−シク
ロプロピルメトキシカルボニルチオー3ーフエノキシア
セトアミドー2−オキソアゼチジン−1−イル)一Q−
(2−フロモ−1一ヒドロキシェチリデン)酢酸2・2
・2ートリクロロェチル434の夕を得る。収率:83
.5%。IR:^縄皮33450、1790、1720
(Sh)、1700肌−10NMR:6CDCム0.1
−1.4m7日、3.9幻(7HZ)2日、4.27d
(5日2)2日、4.57s2日、4.82d(3HZ
)が、5.27dd(6:8HZ)IH、5.9紅(5
Hz)IH、6‐8−7‐5m母日、11.67br−
SIH。■ Q−(4ーシクロプロピルメトキシカルボ
ニルチオ−3−フエノキシアセトアミド−2−オキソア
ゼチジン−1−イル)一Q一(2ーブロモ−1−ヒドロ
キシェチリデン)酢酸2・2・2−トリクロロェチル3
30の9を塩化メチレン6の上にとかし、室温にてかき
まぜながら塩化アルミニウム330の9を加えて60分
間かきまぜる。反応液を氷冷下に稀塩酸に注ぎ酢酸エチ
ルで抽出する。抽出液を稀塩酸と水とで洗い、乾燥した
のち溶媒蟹去すれば7ーフヱノキシアセトアミド−3−
オキソセフアム−4−カルボン酸2・2・2−トリクロ
ロェチル300の9を得る。泡状物。例3
例2【1’の方法に準じてQ−(4−カーボベンゾキシ
チオ−3ーフエノキシアセトアミド−2−オキソアゼチ
ジン−1ーイル)一Q一〔2ーフoモ−1−(ピベリジ
ンー1ーィル)ェチリデン〕酢酸2・2・2ートリクロ
ロヱチルをメタノール中塩酸で加水分解してQ−(4ー
カーポベンゾキシチオー3ーフエノキシアセトアミド−
2ーオキソアゼチジンー1−イル)−Q−(2ーブロモ
ー1−ヒドロキシェチリデン)酢酸2・2・2−トリク
ロロェチルを製造し、これを塩化メチレン中、塩化アル
ミニウムで環化すれば例2{2}と同一の7−フエノキ
ンアセトアミド−3−オキソセフアム一4ーカルボン酸
2・2・2ートリク。After washing the extract with water and drying, the solvent is distilled off to give Q-(4-cyclopropylmethoxycarbonylthio-3-phenoxyacetamido-2-oxoazetidin-1-yl)-Q-
(2-furomo-1-hydroxyethylidene)acetic acid 2.2
- Obtain 434 amounts of 2-trichloroethyl. Yield: 83
.. 5%. IR: ^ rope skin 33450, 1790, 1720
(Sh), 1700 skin-10NMR:6CDCmu0.1
-1.4m 7 days, 3.9 phantom (7HZ) 2 days, 4.27d
(5 days 2) 2 days, 4.57s 2 days, 4.82d (3HZ
) is 5.27dd (6:8HZ) IH, 5.9beni (5
Hz) IH, 6-8-7-5m Mother's Day, 11.67br-
S.I.H. ■ Q-(4-cyclopropylmethoxycarbonylthio-3-phenoxyacetamido-2-oxoazetidin-1-yl)-Q-(2-bromo-1-hydroxyethylidene)acetic acid 2,2,2-trichloroethyl chill 3
Dissolve 9 of 30 on methylene chloride and 6 of methylene chloride, add 9 of aluminum chloride 330 while stirring at room temperature, and stir for 60 minutes. The reaction solution was poured into dilute hydrochloric acid under ice cooling and extracted with ethyl acetate. Washing the extract with dilute hydrochloric acid and water, drying, and removing the solvent yields 7-phenoxyacetamide-3.
9 of 300 2,2,2-trichloroethyl oxocepham-4-carboxylate is obtained. Foamy matter. Example 3 According to the method of Example 2 [1'] Q-(4-carbobenzoxythio-3-phenoxyacetamido-2-oxoazetidin-1-yl) 1-yl)ethylidene] 2,2,2-trichloroethyl acetate was hydrolyzed with hydrochloric acid in methanol to produce Q-(4-carpobenzoxythio 3-phenoxyacetamide).
If 2,2,2-trichloroethyl (2-oxoazetidin-1-yl)-Q-(2-bromo-1-hydroxyethylidene)acetate is produced and cyclized with aluminum chloride in methylene chloride, 7-phenoquinacetamido-3-oxocefam-4-carboxylic acid 2,2,2 tritric as in Example 2 {2}.
ロェチルを得る。例4
‘1)Q一(4ーシクロプロピルメトキシカルボニルチ
オ−3−フエノキシアセトアミド−2ーオキソアゼチジ
ン−1ーイル)一Q一〔2ーフロモー1−(モルホリン
−4−イル)エチリデン〕酢酸p−ニトロベンジル30
0の9をメタノール22Mと塩化メチレン3.5の‘と
にとかし、10%塩酸4泌を加えて窒素気流中室温でか
さまぜる。Obtain Loethil. Example 4 '1) Q-(4-cyclopropylmethoxycarbonylthio-3-phenoxyacetamido-2-oxoazetidin-1-yl)-Q-[2-furomo-1-(morpholin-4-yl)ethylidene]acetic acid p-nitrobenzyl 30
Dissolve 0.9 in 22M methanol and 3.5M methylene chloride, add 10% hydrochloric acid, and stir at room temperature in a nitrogen stream.
2時間後、反応液を氷水に注ぎ、クロロホルムで抽出す
る。After 2 hours, the reaction solution was poured into ice water and extracted with chloroform.
抽出液を水洗し、乾燥したのち溶媒留去すればQ−(4
−シクロプロピルメトキシカルボニルチオー3−フエノ
キシアセトアミド−2ーオキソアゼチジンー1ーイル〕
−Q−(2−フロモ−1−ヒドロキシエチリデン)酢酸
p−ニトロベンジル252の9を得る。泡状物収率:9
2.8%。IR:レ錦髪334201781、171止
1690・1601肌‐IONMR;6CDCZ30
,23一1.33h9日、3.84−4.36m4日、
4.5$2日、5.10−5.32h3日、5.8斑(
5 HZ)IH、6.83−8.33h到日、12.
$IH。■ Q−(4ーシクロプロピルメトキシカルボ
ニルチオ−3−フエノキシアセトアミド−2−オキソア
ゼチジンー1−イル〕−Q−(2ーフロモ−1−ヒド。If the extract is washed with water, dried, and the solvent is distilled off, Q-(4
-cyclopropylmethoxycarbonylthio-3-phenoxyacetamido-2-oxoazetidin-1-yl]
-Q-(2-furomo-1-hydroxyethylidene) p-nitrobenzyl acetate 252-9 is obtained. Foam yield: 9
2.8%. IR:Rekinkami 334201781, 171 stop 1690/1601 skin-IONMR; 6CDCZ30
, 23-1.33h9 days, 3.84-4.36m4 days,
4.5$2 days, 5.10-5.32h3 days, 5.8 spots (
5 HZ) IH, 6.83-8.33h arrival, 12.
$IH. (2) Q-(4-cyclopropylmethoxycarbonylthio-3-phenoxyacetamido-2-oxoazetidin-1-yl)-Q-(2-furomo-1-hydro.
キシェチリデン)酢酸p−ニトロベンジル218の9を
メタノール不含の塩化メチレン2.1の‘にとかし、ア
ルゴン気流中氷冷下に塩化アルミニウム220の9を加
えてかきまぜる。35分後、4N−塩酸4Mを含む氷水
中に反応液を注ぎ、1び分かきまぜたのちクロロホルム
で抽出する。9 of 218 p-nitrobenzyl acetate (quichetylidene) was dissolved in 2.1 of methanol-free methylene chloride, and 9 of 220 of aluminum chloride was added and stirred under ice cooling in an argon stream. After 35 minutes, the reaction solution was poured into ice water containing 4N-4M hydrochloric acid, stirred for 1 minute, and then extracted with chloroform.
抽出液を水洗、乾燥後、溶媒留去すればQ−(4ーメル
カプト−3−フエノキシアセトアミド−2−アゼチジン
ー1−イル)一o−(2−フロモ−1−ヒドロキシエチ
リデン)酢酸p−ニトロベンジル150の9を得る。黄
色泡状物収率:94‐6%。IR:レ級桜334oo、
178o、1692・1610・163肌‐1。NMR
:6鴇弊32.2母(loHZ)IH、4.29(2H
Z)2日、4.5$2日、5.20−5‐37m山日、
6‐84−8.24m到日、12‐ISIH。(3}
Q一(4−メルカプト−3−フエノキシアセトアミドー
2ーオキソアゼチジン−1ーイル−Q−(2ーフロモ−
1−ヒドロキシヱチリデン)酢酸p−ニトロベンジル1
06の夕をベンゼン5泌にとかし、これにメルク社製シ
リカゲルF−254を500雌加えて室温にて1時間振
りまぜる。不溶物を炉去しクロロホルムで数回洗う。炉
、洗液を合し、減圧下溶媒留去すれば3ーヒドロキシー
7−フエノキシアセトアミドー3ーセフヱムー4ーカル
ボン酸p−ニトロベンジル60のcを得る。収率:66
.3%。‘4) 例4■で製造したQ−(4−メルカプ
ト−3ーフエノキシアセトアミド−2ーオキソアゼチジ
ン−1ーイル)一Q−(2−フロモー1−ヒドロキシェ
チリデン)酢酸p−ニトロベンジル70の9を塩化メチ
レン2の【とメタノール2泌との混液にとかし、室温に
て3時間かきまぜる。After washing the extract with water and drying, the solvent is distilled off to obtain Q-(4-mercapto-3-phenoxyacetamido-2-azetidin-1-yl)-o-(2-furomo-1-hydroxyethylidene)acetic acid p-nitro You get benzyl 150 9. Yellow foam yield: 94-6%. IR: Le class Sakura 334oo,
178o, 1692/1610/163 skin-1. NMR
: 6 32.2 mother (loHZ) IH, 4.29 (2H
Z) 2 days, 4.5$2 days, 5.20-5-37m mountain days,
Arrival at 6-84-8.24m, 12-ISIH. (3)
Q-(4-mercapto-3-phenoxyacetamide 2-oxoazetidin-1-yl-Q-(2-furomo-
1-Hydroxyethylidene) p-nitrobenzyl acetate 1
06 was dissolved in 5 parts of benzene, 500 parts of silica gel F-254 manufactured by Merck was added thereto, and the mixture was shaken at room temperature for 1 hour. Remove insoluble matter from the oven and wash with chloroform several times. The washings were combined in a furnace and the solvent was distilled off under reduced pressure to obtain p-nitrobenzyl 3-hydroxy-7-phenoxyacetamide 3-cephalic acid p-nitrobenzyl 4-carboxylate 60. Yield: 66
.. 3%. '4) Q-(4-Mercapto-3-phenoxyacetamido-2-oxoazetidin-1-yl)-Q-(2-furomo-1-hydroxyethylidene)acetic acid p-nitrogen prepared in Example 4■ Dissolve 70 parts of benzyl in a mixture of 2 parts of methylene chloride and 2 parts of methanol, and stir at room temperature for 3 hours.
反応液を氷中に注ぎ塩化メチレンで抽出する。抽出液を
水洗し、硫酸マグネシウム上乾燥したのち溶媒留去すれ
ば例4【3}の生成物と同一の3ーヒドロキシ−7ーフ
エノキシアセトアミド−3ーセフェム−4ーカルボン酸
pーニトロベンジル42雌を得る。収率:70%。t5
} 例4【2}で製造したQ−(4ーメルカプト−3ー
フエノキシアセトアミド−2ーオキソアゼチジン−1ー
イル−)一Q−(2ーブロモ−1一ヒドロキシェチリデ
ン)酢酸pーニトロベンジル70雌を塩化メチレン2泌
、メタノール2の【および10%塩酸0.3の‘の混液
にとかし、室温にて2時間かきまぜる。The reaction solution was poured into ice and extracted with methylene chloride. The extract is washed with water, dried over magnesium sulfate, and the solvent is distilled off to obtain p-nitrobenzyl 3-hydroxy-7-phenoxyacetamido-3-cephem-4-carboxylate 42, which is the same as the product of Example 4 [3}. . Yield: 70%. t5
} p-nitrobenzyl Q-(4-mercapto-3-phenoxyacetamido-2-oxoazetidin-1-yl)-Q-(2-bromo-1-hydroxyethylidene)acetate prepared in Example 4 [2} 70 The female was dissolved in a mixture of 2 parts methylene chloride, 2 parts methanol, and 0.3 parts 10% hydrochloric acid, and stirred at room temperature for 2 hours.
反応液を氷水中に注ぎ、塩化メチレンで抽出する。抽出
液を水洗し、硫酸マグネシウム上乾燥したのち溶媒蟹去
すれば例4【3’の生成物と同一の3ーオキソ−7ーフ
ェノキシアセトアミドセフアム−4ーカルボン酸p−ニ
トロベンジル44.5の9を得る。収率:74%。例5
【1)Q−(4ーカーボベンゾキシチオー3ーフエノキ
シアセトアミド−2ーオキソアゼチジン1ーイル)一Q
一〔2ーフロモー1一(モルホリンー4ーイル)ェチリ
デン〕酢酸p−ニトロベンジル469の9を塩化メチレ
ン4の‘、メタノール4の【および10%塩酸0.8泌
の混液にとかし、室温にて2時間かきまぜる。The reaction solution was poured into ice water and extracted with methylene chloride. The extract was washed with water, dried over magnesium sulfate, and the solvent was removed to give p-nitrobenzyl 3-oxo-7-phenoxyacetamidocephaam-4-carboxylate, the same product as in Example 4 [3'], 44.5-9. get. Yield: 74%. Example 5
[1) Q-(4-carbobenzoxythiol-3-phenoxyacetamido-2-oxoazetidine-1-yl)-Q
Dissolve 9 of 469 of p-nitrobenzyl 1-[2-fromo 1-(morpholin-4-yl)ethylidene]acetate in a mixture of 4 parts of methylene chloride, 4 parts of methanol, and 0.8 parts of 10% hydrochloric acid for 2 hours at room temperature. Stir.
反応液に氷水を加えて塩化メチレンで抽出する。抽出液
を水洗し、硫酸マグネシウム上乾燥したのち溶媒留去す
ればQ−(4−カーポベンゾキシチオ一3−フエノキシ
アセトアミド−2ーオキソアゼチジンー1−イル)Q一
(2ーブロモー1ーヒドロキシェチリデン)酢酸p−ニ
トロベンジル426の9を得る。収率:定量的。IR:
〆溝袋334o8、1788172ふ 1690161
5、1602肌‐1。NMR:6CDCと34.27d
(3HZ)2日、4.4$2日、5.1$2日、5.2
公2日、5.29hIH、5.8的(5HZ)IH、6
.748,2肌畑。‘2’ Q−(4ーカーボベンゾキ
シチオー3ーフヱノキシアセトアミド−2ーオキソアゼ
チジンー1ーイル−Q−(2ーブロモー1一ヒドロキシ
ェチリデン)酢酸pーニトロベンジル480の9を20
%ニトロメタン含有塩化メチレン5の上にとかし、これ
に塩化アルミニウム270の9を20%ニトロメタン含
有塩化メチレン4の‘にとかして加え、室温にて1時間
かきまぜる。Add ice water to the reaction solution and extract with methylene chloride. The extract was washed with water, dried over magnesium sulfate, and the solvent was distilled off to give Q-(4-carpobenzoxythio-3-phenoxyacetamido-2-oxoazetidin-1-yl)Q-(2-bromo-1). -hydroxyethylidene) p-nitrobenzyl acetate 426-9 is obtained. Yield: Quantitative. IR:
Closing bag 334o8, 1788172fu 1690161
5, 1602 skin-1. NMR: 6CDC and 34.27d
(3HZ) 2 days, 4.4 $2 days, 5.1 $2 days, 5.2
Public 2nd, 5.29hIH, 5.8 (5HZ) IH, 6
.. 748, 2 skin fields. '2' Q-(4-carbobenzoxythio 3-phenoxyacetamido-2-oxoazetidin-1-yl-Q-(2-bromo-1-hydroxyethylidene) p-nitrobenzyl acetate 480 of 9 to 20
To this, 270 parts of aluminum chloride is dissolved in 4 parts of methylene chloride containing 20% nitromethane, and the mixture is stirred at room temperature for 1 hour.
反応液を稀塩酸に注ぎ、塩化メチレンで抽出する。抽出
液を水洗し、硫酸マグネシウム上乾燥したのち、溶媒蟹
去すればQ−(4−メルカプトー3ーフェノキシアセト
アミド−2ーオキソアゼチジン−1−イル)一Q−(2
ーフロモー1−ヒドロキシヱチリデン)酢酸pニトロベ
ンジル376の9を得る。収率:99.5%。例6
Q−(4ーシクロプロピルメトキシカルボニルチオー3
ーフエノキシアセトアミドー2ーオキソアゼチジン−1
ーイルーQ−〔2ーフロモ−1−(モルホリン−4−ィ
ル)ェチリデン酢酸p−ニトロベンジル151の9を塩
化メチレン1.5私にとかし、これに塩化アルミニウム
142地を加えて氷冷下に5雌仇)さまぜる。The reaction solution was poured into dilute hydrochloric acid and extracted with methylene chloride. The extract was washed with water, dried over magnesium sulfate, and the solvent was removed to give Q-(4-mercapto-3-phenoxyacetamido-2-oxoazetidin-1-yl)-Q-(2
-furomor 1-hydroxyethylidene) p-nitrobenzyl acetate 376-9 is obtained. Yield: 99.5%. Example 6 Q-(4-cyclopropylmethoxycarbonylthio3
-Phenoxyacetamide 2-Oxoazetidine-1
-Ilu Q- [2-Furomo-1-(morpholin-4-yl)ethylidene p-nitrobenzyl acetate 151-9 was dissolved in 1.5 methylene chloride, and aluminum chloride 142 was added thereto, and the solution was dissolved under ice-cooling for 5. (female enemy) to stir.
反応液に氷水2の‘を加えて5分かきまぜたのち、メタ
ノール+塩化メチレン(5:1)混液15の【および1
0%塩酸3泌を加えて室塩にて80分間かきまぜる。反
応液に氷水を加えてクロロホルムで抽出する。抽出液を
水洗し硫酸マグネシウム上乾燥したのち溶媒留去すれば
3ーヒドロキシー7ーフエノキシアセトアミドー3ーセ
フヱムー4−カルボン酸p−ニトロベンジル63の9を
得る。収率:63%。この生成物は例4脚の生成物と同
一であって、反応により4ーモルホリノ基が加水分解さ
れてヒドロキシ基と置換したものである。例7
Q−〔4一(ベンゾチアゾールー2−イル)ジチオー3
ーフエノキシアセトアミド−2ーオキソアゼジンー1−
イル〕−Q一(2ーフロモー1一ヒドロキシェチリデン
)酢酸2・2・2−トリクロロエチル100のoをエタ
ノール10のとにとかし、0℃にて水素化ほう素ナトリ
ウム5の9を加えて1おテかきまぜる。Add 2 parts of ice water to the reaction solution and stir for 5 minutes, then add 15 parts of a methanol + methylene chloride (5:1) mixture [and 1
Add 0% hydrochloric acid trichloride and stir with room salt for 80 minutes. Add ice water to the reaction solution and extract with chloroform. The extract was washed with water, dried over magnesium sulfate, and then the solvent was distilled off to obtain p-nitrobenzyl 3-hydroxy-7-phenoxyacetamido-3-ceph-4-carboxylate p-nitrobenzyl 63-9. Yield: 63%. This product is identical to the product of Example 4, in which the 4-morpholino group is hydrolyzed and replaced by a hydroxy group in the reaction. Example 7 Q-[4-(benzothiazol-2-yl)dithio 3
-Phenoxyacetamide-2-oxoazedine-1-
]-Q-(2-furomo-1-hydroxyethylidene) 100 parts of 2,2,2-trichloroethyl acetate was dissolved in 10 parts of ethanol, and 5 parts of sodium borohydride was added at 0°C. 1 Stir.
反応液に数滴の氷酢酸と水を加えたのち酢酸エチルで抽
出する。抽出液を水洗、乾燥後、溶媒留去する。残留物
をN・N−ジメチルホルムアミド4の‘にとかし、これ
にトリフエニルホスフイン30のoを加え、室温にて1
.5時間かきまぜたのち酢酸エチルで稀釈する。この溶
液を水洗、乾燥後、溶媒留去する。残留する7−フェノ
キシアセトアミド−3−オキソセフアムー4ーカルボン
酸2・2・2−トリクロロェチルを塩化メチレン4の‘
にとかしジアゾメタンのェーーテル溶液を加えて室温に
て25分間かきまぜる。溶媒蟹去して得られる残留物を
薄層クロマトグラフィーで精製すれば7ーフエノキシア
セトアミド−3−メトキシー3ーセフェムー4ーカルボ
ン酸2・2・2−トリクロロェチルを得る。この生成物
は別途合成した標品とIRおよび薄層クロマトグラムの
Rfで同定できる。例8
前例と同様にして次の化合物を製造できる。A few drops of glacial acetic acid and water are added to the reaction mixture, and then extracted with ethyl acetate. After washing the extract with water and drying, the solvent is distilled off. The residue was dissolved in 4 parts of N-N-dimethylformamide, 30 parts of triphenylphosphine was added thereto, and the mixture was diluted with 1 part of triphenylphosphine at room temperature.
.. After stirring for 5 hours, dilute with ethyl acetate. After washing this solution with water and drying, the solvent was distilled off. The remaining 7-phenoxyacetamido-3-oxocephalic acid 2,2,2-trichloroethyl 4-carboxylate was dissolved in methylene chloride 4'
Add an ether solution of diluted diazomethane and stir at room temperature for 25 minutes. The residue obtained by removing the solvent is purified by thin layer chromatography to obtain 2,2,2-trichloroethyl 7-phenoxyacetamido-3-methoxy-3-cephemu-4-carboxylate. This product can be identified from a separately synthesized standard product by IR and Rf in thin layer chromatograms. Example 8 The following compound can be prepared in the same manner as in the previous example.
【1} 7ーフタルイミドー3ーヒドロキシ−3−セフ
ェムー4−カルボン酸メチル;(2) 7ーフエノキシ
アセトアミド−3一(モルホリンー4−イル)−3ーセ
フエムー4−力ルボン酸2・2・2−トリクロロェチル
;【3’ 7−フタルイミドー3ークロロー3ーセフエ
ム−4ーカルボン酸メチル:‘4)7−フエニルアセト
アミド一3ーベンジルチオー3ーセフェム−4ーカルボ
ン酸2・2・2−トリクロロエチル;【5)7−(2・
2−ジメチル−3ーニトロソー4ーフエニルー5ーオキ
ソイミダゾリジンー1ーイル)一3−ヒドロキシー3ー
セフヱム−4−カルボン酸pーメトキシベンジル:‘6
’ 7一(N−第三級ブトキシカルボニル−Q−フエニ
ルグリシル)アミノ−3ーオキソセフアムー4−カルボ
ン酸pーニトロベンジル。[1} Methyl 7-phthalimido-3-hydroxy-3-cephemu-4-carboxylate; (2) 7-phenoxyacetamido-3-(morpholin-4-yl)-3-cephemu-4-carboxylic acid 2,2,2-trichloro Ethyl; [3' Methyl 7-phthalimido-3-chloro-3-cephem-4-carboxylate: '4) 2,2,2-trichloroethyl 7-phenylacetamido-13-benzylthio-3-cephem-4-carboxylate; [5) 7- (2・
p-Methoxybenzyl 2-dimethyl-3-nitroso-4-phenyl-5-oxoimidazolidin-1-yl)-3-hydroxy-3-cephem-4-carboxylate: '6
'7-(N-tert-butoxycarbonyl-Q-phenylglycyl)amino-3-oxocephalomu-4-carboxylic acid p-nitrobenzyl.
‘7} 7ーチエニルアセトアミドー3−ヒドロキシー
3−セフェム−4−カルボン酸2・2・2ートリク。'7} 7-Thienylacetamide 3-hydroxy-3-cephem-4-carboxylic acid 2.2.2 trit.
ロエチル;【81 7−サリチリデンアミノー3ーヒド
ロキシー3ーセフェム−4ーカルボン酸p−ニトロベン
ジル;‘9} 7−ペンジルオキシカルボニルアミノ−
3ーヒドロキシー3ーセフェム−4ーカルポン酸2・2
・2ートリクロロエチル;007一(2・2・2−トリ
クooエトキシカルボニル)アミノ−3ーヒドロキシ−
3ーセフエム−4ーカルボン酸pーニトロベンジル。Loethyl; [81 p-nitrobenzyl 7-salicylideneamino-3-hydroxy-3-cephem-4-carboxylate; '9} 7-penzyloxycarbonylamino-
3-hydroxy-3-cephem-4-carboxylic acid 2.2
・2-Trichloroethyl; 007-(2.2.2-tricooethoxycarbonyl)amino-3-hydroxy-
p-nitrobenzyl 3-cephem-4-carboxylate.
例9
Q−(3ーフエノキシメチル−7ーオキソ−4−チア−
2・6ージアザビシクロ〔3・2・0〕へプトー2ーエ
ン−6ーイル)一Q−〔2−フロモー1−(モルホリン
ー4ーイル)エチリデン〕酢酸2・2・2ートリクoo
メチル6.00夕をクロロホルム150の‘とメタノー
ル200私との混液にとかし、室温にて10%塩酸40
の‘を加え、6び分間かきまぜる。Example 9 Q-(3-phenoxymethyl-7-oxo-4-thia-
2,6-diazabicyclo[3.2.0]heptot-2-en-6-yl)-Q-[2-furomo-1-(morpholin-4-yl)ethylidene]acetic acid 2.2.2-trichoo
Dissolve 6.00 g of methyl in a mixture of 150 g of chloroform and 200 g of methanol, and add 40 g of 10% hydrochloric acid at room temperature.
Add '' and stir for 6 minutes.
反応液を氷水に注ぎ、クロロホルムで抽出する。抽出液
を水洗、乾燥後、溶媒留去すれば3ーオキソ−7ーフエ
ノキシアセトアミドセフアム−4−カルボン酸2・2・
2ートリクロロェチル4.70夕を得る。泡状物。収率
:99.8%。例 10Q−3ーフエノキシメチルー7
−オキソ−4ーチアー2・6ージアザビシクロ〔3・2
・0〕へプト−2−ヱンー6−イル〕一Q一〔2ーフロ
モー1一(モルホリンー4ーィル)ェチリデン〕酢酸p
ーニトロベソジル63雌をメタノール4の‘と塩化メチ
レン3の上との混液にとかし、これに10%塩酸0.3
8の‘を加えて室温にて75分かきまぜる。Pour the reaction solution into ice water and extract with chloroform. After washing the extract with water and drying, the solvent is distilled off to obtain 3-oxo-7-phenoxyacetamidocepham-4-carboxylic acid 2.2.
Obtain 4.70 ml of 2-trichloroethyl. Foamy matter. Yield: 99.8%. Example 10Q-3-phenoxymethyl-7
-oxo-4-thia2,6-diazabicyclo [3,2
・0]hept-2-en-6-yl]1Q1[2-fromo11(morpholine-4-yl)ethylidene]acetic acid p
Nitrobesodil 63 female was dissolved in a mixture of 4 parts of methanol and 3 parts of methylene chloride, and this was mixed with 0.3 parts of 10% hydrochloric acid.
Add 8' and stir at room temperature for 75 minutes.
反応液を氷水に注ぎ、塩化メチレンで抽出する。抽出液
を水洗し、硫酸マグネシウム上乾燥したのち、溶媒留去
すれば3ーヒドロキシ−7−フェノキシアセトアミドー
3ーセフェムー4ーカルポン酸p−ニトロベンジル41
の9を得る。mp95.5〜99.5℃。収率:82.
9%。例11
Q一(3−フエノキシメチル−7ーオキソ−4ーチア−
2・6ージアザビシクロ〔3・2・0〕へプトー2ーエ
ン−6−イル)一Q−〔2ークロロー1一(モルホリン
−4ーイル)エチリデン〕酢酸p−ニトロベンジル10
6の9をメタノール+塩化メチレン(2:1)混液6叫
にとかし、これに洲−塩酸0.93泌を加えてアルゴン
気流中、室温でかきまぜる。Pour the reaction solution into ice water and extract with methylene chloride. The extract was washed with water, dried over magnesium sulfate, and the solvent was distilled off to give p-nitrobenzyl 3-hydroxy-7-phenoxyacetamide 3-cephemu-4-carboxylate 41.
get 9. mp95.5-99.5°C. Yield: 82.
9%. Example 11 Q-(3-phenoxymethyl-7-oxo-4-thia-
2,6-diazabicyclo[3.2.0]hept-2-en-6-yl)-Q-[2-chloro1-(morpholin-4-yl)ethylidene]p-nitrobenzyl acetate 10
Dissolve 9 of 6 in a mixture of methanol and methylene chloride (2:1), add 0.93 g of Su-hydrochloric acid, and stir at room temperature in an argon stream.
40分後、氷水で稀釈し、塩化メチレンで抽出する。After 40 minutes, dilute with ice water and extract with methylene chloride.
抽出液を水洗し、硫酸マグネシゥム上乾燥したのち溶媒
蟹去すれば黄色油状物94夕を得る。これをシリカゲル
上薄層クロマトグラフィーにより精製し、ベンゼン+酢
酸エチル(1:2)濠液で流出する分画より3−ヒドロ
キシー7ーフエノキシアセトアミドー3ーセフエム−4
−カルボン酸p−ニトロベンジル20の9を得る。収率
:22%。例 12
Q一(3ーベンジル−7−オキソー4−チア−2・6ー
ジアザビシクロ〔3・2・0〕へプト−2ーエン−6ー
イル〕−Q一〔2ーブロモー1一(モルホリンー4ーィ
ル)ェチリデン〕酢酸2・2・2ートリクロロエチル1
17の9をメタノール+クロロホルム(1:1)涙液4
の‘にとかし、10%塩酸0.5Mを加えて室温で2時
間かきまぜる。The extract was washed with water, dried over magnesium sulfate, and the solvent was removed to give a yellow oil. This was purified by thin layer chromatography on silica gel, and the fractions flowing out with benzene + ethyl acetate (1:2) were collected from 3-hydroxy-7-phenoxyacetamide 3-cephem-4.
-9 of p-nitrobenzyl carboxylate 20 is obtained. Yield: 22%. Example 12 Q1(3-benzyl-7-oxo4-thia-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl)-Q1[2-bromo11(morpholine-4yl)ethylidene] 2,2,2-trichloroethyl acetate 1
9 of 17 methanol + chloroform (1:1) tear fluid 4
Add 10% hydrochloric acid (0.5M) and stir at room temperature for 2 hours.
反応液をクロロホルムで抽出する。抽出液を水洗、乾燥
後、溶媒留去する。残留物をシリカゲル・クロマトグラ
フィーにより精製すれば3ーオキソ−7ーフエニルアセ
トアミドセフアムー4ーカルボン酸2・2・2ートリク
ロロェチル41の9を得る。収率:44%。例 13
Q一(3ーベンジルー7ーオキソー4−チアー2・6−
ジアザビシクロ〔3・2・0〕へプトー2ーエン−6ー
イル)一Q一〔2ーブロモ−1一(モルホリンー4−イ
ル)ェチリデン〕酢酸p−ニトロベンジル248mgを
メタノール8の【と塩化メチレン6の‘の鷹液にとかし
、氷袷下10%塩酸1.5舷を加えて2時間かきまぜる
。Extract the reaction solution with chloroform. After washing the extract with water and drying, the solvent is distilled off. Purification of the residue by silica gel chromatography yields 9 of 2,2,2-trichloroethyl 3-oxo-7-phenylacetamidocephalic acid 4-carboxylate 41. Yield: 44%. Example 13 Q1 (3-benzyru7-oxo4-thia2.6-
Diazabicyclo[3.2.0]hept-2-en-6-yl)-Q-[2-bromo-1-(morpholin-4-yl)ethylidene]p-nitrobenzyl acetate (248 mg) was mixed with 8 parts of methanol and 6 parts of methylene chloride. Dissolve in falcon solution, add 1.5 g of 10% hydrochloric acid under ice, and stir for 2 hours.
反応液を氷水に注ぎ、塩化メチレンで抽出する。抽出液
を水洗し、硫酸マグネシウム上乾燥後、溶媒留去して得
られる残留物184の9を10%含水シリカゲル10タ
上クロマトグラフして精製し、ベンゼン十酢酸エチル(
2:1)混液で流出する分画を溶媒蟹去すれば7−フエ
ニルアセトアミド−3−ヒドロキシー3ーセフェム−4
ーカルボン酸pーニトロベンジル6鰍9を得る。油状物
。収率:35%。例14
前例と同様にして次の化合物を製造できる。Pour the reaction solution into ice water and extract with methylene chloride. The extract was washed with water, dried over magnesium sulfate, and the solvent was distilled off. The resulting residue 184:9 was purified by chromatography on 10% aqueous silica gel and purified with benzene-ethyl decacetate (
2:1) If the solvent is removed from the fraction flowing out of the mixed solution, 7-phenylacetamido-3-hydroxy-3-cephem-4 is obtained.
-P-nitrobenzyl carboxylate 6 and 9 were obtained. Oily substance. Yield: 35%. Example 14 The following compound can be prepared similarly to the previous example.
【1) 7ーアセトアミドー3ーオキソセフアムー4−
カルボン酸1・2ージィソプ。ピルヒドラジド;(2}
7ーフエノキシアセトアミドー3ーヒドロキシ−3ー
セフェムー4−カルポン酸ジフェニルメチル:【3}
7ーフヱニルアセトアミドー3ーヒドロキシー3−セフ
ェムー4ーカルボン酸。[1] 7-acetamido 3-oxocephalomu 4-
Carboxylic acid 1,2-disop. Pyrhydrazide; (2}
7-Phenoxyacetamide 3-hydroxy-3-cephemu 4-carboxylic acid diphenylmethyl: [3}
7-phenylacetamido-3-hydroxy-3-cephemu-4-carboxylic acid.
例15
Q−(3ーフエノキシメチル−7−オキソ−4ーチア−
2・6ージアザビシクロ〔3・2・0〕へプトー2ーエ
ンー6ーイル)一Q一〔2−フロモ−1−(モルホリン
−4−イル)エチリデン〕酢酸pーニトロベンジル58
0の9をテトラヒドロフラン10の‘にとかし、これを
−10qoに冷却下に60%過塩素酸水溶液1.5w‘
を加えて、30分間かきまぜる。Example 15 Q-(3-phenoxymethyl-7-oxo-4-thia-
2,6-diazabicyclo[3.2.0]hepto-2-en-6-yl)-Q-[2-furomo-1-(morpholin-4-yl)ethylidene]p-nitrobenzyl acetate 58
Dissolve 9 of 0 in 10 of tetrahydrofuran, and add 1.5 w of 60% perchloric acid aqueous solution while cooling to -10 qo.
Add and stir for 30 minutes.
反応液を過剰の水で稀釈したのち塩化メチレンで抽出す
る。抽出液を水洗し、無水硫酸ナトリウム上乾燥後、溶
媒蟹去すれば淡黄色泡状物512の9を得る。これを1
0%合水シリカゲル50タ上ク。マトグラフして分離精
製すればベンゼン+酢酸エチル(1:1)混液により流
出する分画よりQ−(3ーフエノキシメチル−7ーオキ
ソー4−チアー2・6ージアザビシクロ〔3・2・0〕
へプトー2ーエンー6−イル)一Q−(2−フロモ−1
−ヒドロキシェチリデン)酢酸p−ニトロベンジル20
7のc(泡状物:収率40%)を得る。IR:〃鴇袋3
1781肌‐I。NMR:6CDCと33.75十3.
9松Bq(10日2)2日、4.77s2日、5.2$
2日、5.7紅(4日2)IH、6.07d(4HZ)
IH、6.73〜8.18h鮒、12.07sIH。な
お、Q−(3ーフヱノキシアセトアミド−2−メルカプ
トー4−オキソアゼチジン−1−イルーQ一(2ーフロ
モ−1−ヒドロキシエチリデン)酢酸pーニトロベンジ
ルを副生する。The reaction solution was diluted with excess water and then extracted with methylene chloride. The extract is washed with water, dried over anhydrous sodium sulfate, and the solvent is removed to obtain 512-9 as a pale yellow foam. This is 1
50% hydrated silica gel. After separation and purification by chromatography, the fraction flowing out with a mixture of benzene and ethyl acetate (1:1) was extracted from Q-(3-phenoxymethyl-7-oxo-4-thia2,6-diazabicyclo[3.2.0]
hepto-2-en-6-yl)-Q-(2-fromo-1
-hydroxyethylidene) p-nitrobenzyl acetate 20
7c (foam: yield 40%) is obtained. IR: Tokibukuro 3
1781 Skin-I. NMR: 6CDC and 33.75 13.
9matsu Bq (10 days 2) 2 days, 4.77s 2 days, 5.2 dollars
2nd, 5.7 red (4th 2nd) IH, 6.07d (4HZ)
IH, 6.73-8.18h crucian carp, 12.07sIH. In addition, Q-(3-phenoxyacetamido-2-mercapto-4-oxoazetidin-1-yl-Q-(2-furomo-1-hydroxyethylidene) p-nitrobenzyl acetate is produced as a by-product.
前記主生成物84の9をテトラヒドロフラン2の上にと
かし、これに洲‐塩酸0.2肌を加えて0℃に30分間
および室温に1時間放置する。9 of the main product 84 is dissolved in 2 parts of tetrahydrofuran, 0.2 parts of S-HCl is added thereto, and the mixture is left at 0° C. for 30 minutes and at room temperature for 1 hour.
反応液を過剰の水で稀釈したのち、塩化メチレンで抽出
する。抽出液を水洗し、無水硫酸ナトリウム上乾燥した
のち溶媒蟹去する。残留物75雌はIRおよびNM旧に
より7−フエノキシアセトアミド−3−オキソセフアム
ー4ーカルボン酸p−ニトロベンジルと同定される。例
16
Q一(3ーベンジルー7ーオキソ−4ーチア−2・6ー
ジアザビシクロ〔3・2・0〕へブトー2ーエンー6−
イル)一Q一(1一ヒドロキシエチリデン)酢酸ジフェ
ニルメチル4.84夕をテトラヒドロフラン60の【に
とかし、一2000にてかきまぜながら、トリェチルア
ミン2.84の‘を加え、黄色となった溶液に塩化メタ
ンスルホニル0.82のZを滴下したのち30分間反応
させる。After diluting the reaction solution with excess water, it is extracted with methylene chloride. The extract was washed with water, dried over anhydrous sodium sulfate, and then the solvent was removed. Residue 75 is identified by IR and NM as p-nitrobenzyl 7-phenoxyacetamido-3-oxocephalic acid 4-carboxylate. Example 16 Q-(3-benzy-7-oxo-4-thia-2,6-diazabicyclo[3.2.0]buto-2-en-6-
Dissolve 4.84 g of diphenylmethyl 1-(1-hydroxyethylidene)acetate in 60 g of tetrahydrofuran, add 2.84 g of triethylamine while stirring at 12,000 g, and add methane chloride to the yellow solution. After dropping Z of 0.82 sulfonyl, the mixture is allowed to react for 30 minutes.
生成したQ−(3−ペンジル−7ーオキソ−4ーチアー
2・6ージアザビシクロ〔3・200〕へプト−2−エ
ソー6−イル)−Q一(1ーメタンスルホニルオキシヱ
チリデン)酢酸ジフェニルメチルの溶液を−40ooに
冷却し、これにモルホリン0.96Mを加え、3.5時
間かきまぜる。生成したQ−(3ーベンジル−7ーオキ
ソ−4ーチアー2・6−ジアザピシクロ〔3・2・0〕
へプト−2−エン−6−イル)一Q−(1−モルホリノ
ェチリデン)酢酸ジフェニルメチルの溶液にピリジン0
.77Mを加えて−40℃に冷却し、臭素0.49の‘
を加えて30分間かきまぜればQ一(3ーベンジル−7
−オキソー4−チア−216ージアザビシクロ〔3’2
・0〕へプトー2−エンー6ーイル)−Q一(2ーフロ
モ−1一モルホリノェチリデン)酢酸ジフェニルメチル
の溶液を得る。この溶液に5%塩酸72の‘とメタノー
ル60の‘とを滴下したのち、室温にて3時間かきまぜ
たのち、氷室中に一夜放置する。反応液を減圧濃縮し、
残留物を塩化メチレンにとかして水洗し、硫酸ナトリウ
ム上、乾燥し、溶媒蟹去する。残留物5.83夕を10
%含水シリカゲル150タ上、カラムクロマトグラフし
て精製し、ベンゼン+酢酸エチル混液(4:1)で流出
する分画をnーヘキサソで結晶化させれば7ーフェニル
アセトアミドー3−ヒドロキシ−3ーセフエムー4ーカ
ルボン酸ジフェニルメチル3.519を得る。mp93
〜96℃。収率:70%。IR:ひ錨鰭3341o、1
782、1674、1610肌‐1。Nh位:6CDC
ム3.2$2日、3.6$が、4.97d(4HZ)I
H、5.6母d(9:4)IH、6.77d(9)IH
、6.9$IH、7.35ml斑。例 17Q一(3ー
ベンジル−7−オキソ−4−チア−2・6ージアザビシ
クロ〔3・2・0〕へプト−2ーエン−6−イル)一Q
一(1一ヒドロキシエチリデン)酢酸pーニトロベンジ
ル9.06夕をテトラヒドロフラン120の‘に懸濁し
、窒素気流中、一2000でかきまぜながら、トリェチ
ルアミン5.68机上を加えてかきまぜ、透明な溶液と
する。of the produced Q-(3-penzyl-7-oxo-4-thia-2,6-diazabicyclo[3,200]hept-2-eso-6-yl)-Q-(1-methanesulfonyloxyethylidene) diphenylmethyl acetate. Cool the solution to -40oo, add morpholine 0.96M and stir for 3.5 hours. The generated Q-(3-benzyl-7-oxo-4-thia2,6-diazapicyclo[3.2.0]
Hept-2-en-6-yl)-Q-(1-morpholinoethylidene)diphenylmethyl acetate in a solution of pyridine 0
.. Add 77M and cool to -40°C to remove 0.49' of bromine.
If you add and stir for 30 minutes, Q1 (3-benzyl-7
-oxo-4-thia-216-diazabicyclo[3'2
A solution of 0]hept-2-en-6-yl)-Q-(2-furomo-1-morpholinoethylidene)diphenylmethyl acetate is obtained. After adding 72 parts of 5% hydrochloric acid and 60 parts of methanol dropwise to this solution, the mixture was stirred at room temperature for 3 hours, and then left in an ice chamber overnight. Concentrate the reaction solution under reduced pressure,
The residue was dissolved in methylene chloride, washed with water, dried over sodium sulfate and stripped of the solvent. Residue 5.83 10
Purification is achieved by column chromatography on 150% hydrous silica gel, and the resulting fraction is crystallized with n-hexane using a mixture of benzene and ethyl acetate (4:1) to yield 7-phenylacetamide 3-hydroxy-3-cephemu. 3.519 diphenylmethyl 4-carboxylate is obtained. mp93
~96℃. Yield: 70%. IR: Hi-anchor fin 3341o, 1
782, 1674, 1610 skin-1. Nh rank: 6CDC
3.2$2 days, 3.6$ is 4.97d(4HZ)I
H, 5.6 mother d (9:4) IH, 6.77 d (9) IH
, 6.9$ IH, 7.35ml plaque. Example 17Q-(3-benzyl-7-oxo-4-thia-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl)-Q
Suspend 9.06 g of p-nitrobenzyl mono(11-hydroxyethylidene)acetate in 120 g of tetrahydrofuran, stir at 12,000 g in a nitrogen stream, and add 5.6 g of triethylamine and stir to form a clear solution.
これに塩化メタンスルホニル1.65の上を加え、同温
度で30分間かきまぜる。これにモルホリン1.92の
とを加え、0℃まで昇温したのち3.虫時間かきまぜる
。次に内温−30〜一3500まで冷却し、ピリジン1
.54叫と臭素3.12夕とを加える。20分間かきま
ぜたのち、氷水温まで昇温し「 5%塩酸144の‘と
メタノ−ル120の‘とを加える。Add 1.65 g of methanesulfonyl chloride to this and stir at the same temperature for 30 minutes. After adding 1.92% of morpholine to this and raising the temperature to 0°C, 3. Stir the insect time. Next, cool the internal temperature to -30 to -3500, and
.. Add 54 ml and 3.12 ml of bromine. After stirring for 20 minutes, the temperature was raised to ice water temperature and 144 parts of 5% hydrochloric acid and 120 parts of methanol were added.
溶液を室温で3時間かきまぜ、0℃に一夜放置して、析
出する結晶を炉敬すれば7一フエニルアセトアミド−3
−ヒドロキシ−3−セフェム−4ーカルボン酸p−ニト
ロベンジル6.678夕を得る。mp20100。収率
:71%。例 18Q−(3ーベンジルー7ーオキソ−
4−チア−216−ジアザビシクロ〔3・2・0〕へブ
ト−2ーエン−6ーイル)一Q一(2−フロモー1ージ
メチルアミノェチリデン)酢酸pーニトoベンジル38
0の9をテトラヒドロフラン10叫にとかし、これに5
%硫酸12Mとメタノール10の上とを加えて、室温で
2時間かきまぜる。The solution was stirred at room temperature for 3 hours, left at 0°C overnight, and the precipitated crystals were examined to form 7-phenylacetamide-3.
6.678 g of p-nitrobenzyl-hydroxy-3-cephem-4-carboxylate are obtained. mp20100. Yield: 71%. Example 18Q-(3-benzy-7-oxo-
38
Dissolve 9 of 0 in 10 of tetrahydrofuran and add 5 to this.
Add 12M % sulfuric acid and 10% methanol and stir at room temperature for 2 hours.
Claims (1)
ミノまたは置換アミノ)−2−オキソアゼチジン−1−
イル〕−α−(2−ハロ−1−置換アルキリデンまたは
2−ハロ−1−置換アルキル)酢酸またはそのカルボキ
シ基における誘導体を環化反応に付して、7−(アミノ
または置換アミノ)−3−置換−(セフエムまたはセフ
アム)−4−カルボン酸またはそのカルボキシ基におけ
る誘導体を製造することを特徴とするセフエム骨格の環
化製法。[Scope of Claims] 1 α-[4-mercapto or substituted thio)-3-(amino or substituted amino)-2-oxoazetidine-1-
yl]-α-(2-halo-1-substituted alkylidene or 2-halo-1-substituted alkyl)acetic acid or its derivative at the carboxy group is subjected to a cyclization reaction to form 7-(amino or substituted amino)-3 -Substituted-(cephem or cephaem)-4-carboxylic acid or its derivative at the carboxy group is produced. A process for cyclization of a cepheme skeleton.
Priority Applications (83)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP50028452A JPS609516B2 (en) | 1975-03-07 | 1975-03-07 | Cyclization method for Cefem skeleton |
CA000245317A CA1136132A (en) | 1975-02-17 | 1976-02-09 | Cyclization to form cephem ring and intermediates therefor |
SE7601715A SE421691B (en) | 1975-02-17 | 1976-02-16 | NEW AZETID COMPOUNDS FOR USE AS INTERMEDIATES FOR THE MANUFACTURE OF 3-CEFEM SOCIETIES |
DK061976A DK156575C (en) | 1975-02-17 | 1976-02-16 | METHOD OF PREPARING 3-HYDROXY-3-CEPHEM OR 3-OXO-CEPHAM CARBOXYLIC ACID DERIVATIVES |
IL57541A IL57541A (en) | 1975-02-17 | 1976-02-16 | 7-oxo-alpha-4-thia-2,6-diazabicyclo(3,2,0)heptene derivatives,process for their preparation and their cyclization to form cephem compounds and pharmaceutical compositions comprising said cephem compounds |
PT64806A PT64806B (en) | 1975-02-17 | 1976-02-16 | Process of cyclization to form cephem ring and intermediate products for same |
IL49048A IL49048A (en) | 1975-02-17 | 1976-02-16 | Cyclization process to form a cephem ring and intermediates therefor |
MX890676U MX6599E (en) | 1975-03-07 | 1976-02-17 | PROCEDURE FOR THE PREPARATION OF MERCAPTOACETIDINE COMPOUNDS |
GB41073/78A GB1548642A (en) | 1975-02-17 | 1976-02-17 | 2-oxo-azetidine acetic acids |
NZ184637A NZ184637A (en) | 1975-02-17 | 1976-02-17 | Method of cleaving a thiazoline ring |
AU11181/76A AU508160B2 (en) | 1975-02-17 | 1976-02-17 | Cyclization |
BG034106A BG25216A3 (en) | 1975-02-17 | 1976-02-17 | A method of obtaining mercaptoazetidyne derivatives |
MX890376U MX6598E (en) | 1975-03-07 | 1976-02-17 | PROCEDURE FOR THE PREPARATION OF ENAMINES OF COMPOUNDS 3-HIDROXI-3-CEFEM |
IE313/76A IE42479B1 (en) | 1975-02-17 | 1976-02-17 | Cyclization to form a cephem ring and intermediates therefor |
DD7600195998A DD127902A5 (en) | 1975-02-17 | 1976-02-17 | METHOD FOR PRODUCING MERCAPTOAZETIDINE DERIVATIVES |
CH191876A CH627160A5 (en) | 1975-02-17 | 1976-02-17 | Process for preparing halogenated azetidinone or thiazolinoazetidinone derivatives |
BE164401A BE838656A (en) | 1975-02-17 | 1976-02-17 | CYCLING PROCESS LEADING TO THE CYCLE OF CEPHEME AND INTERMEDIARIES FOR ITS EXECUTION |
BG034108A BG25076A3 (en) | 1975-02-17 | 1976-02-17 | A method of obtaining mercapto-azetidine derivatives |
NZ184641A NZ184641A (en) | 1975-02-17 | 1976-02-17 | Mercaptoazetidines, intermediates for cephem ring compounds |
DD7600195997A DD127901A5 (en) | 1975-02-17 | 1976-02-17 | METHOD FOR PRODUCING MERCAPTOAZETIDINE DERIVATIVES |
FR7604318A FR2334669A1 (en) | 1975-02-17 | 1976-02-17 | CYCLING PROCESS FOR FORMING A CORE OF CEPHEM AND NEW PRODUCTS THUS OBTAINED |
NZ184640A NZ184640A (en) | 1975-02-17 | 1976-02-17 | Derivatives of 7-oxo-4-thia-2,6-diazo-bicyclic-hept-2-enes |
YU384/76A YU40272B (en) | 1975-02-17 | 1976-02-17 | Process for producing beta-lactamine compounds |
DD7600195993A DD127899A5 (en) | 1975-02-17 | 1976-02-17 | PROCESS FOR THE PREPARATION OF CEPHEM COMPOUNDS |
NZ184638A NZ184638A (en) | 1975-02-17 | 1976-02-17 | Derivatives of 7-oxo-4-thia-2,6-diazobicylic-hept-2-enes |
RO7694586A RO75006A (en) | 1975-02-17 | 1976-02-17 | PROCESS FOR THE PREPARATION OF MERCAPTOAZETIDINONE |
BG032385A BG24948A3 (en) | 1975-02-17 | 1976-02-17 | A method of obtaining beta-lactam compounds |
BG034105A BG24949A3 (en) | 1975-02-17 | 1976-02-17 | A method of obtaining mercaptoazetidine derivatives |
PL1976212107A PL114457B1 (en) | 1975-03-07 | 1976-02-17 | Process for preparing novel derivatives of mercaptoazetidine |
AR262283A AR225878A1 (en) | 1975-02-17 | 1976-02-17 | NEW DERIVATIVES OF 3-AMINO-2-AZETIDINON-1 - ((2-HALO-ACETIL OR 2-HALOETILIDEN)) - ACETIC, PROCEDURE TO PREPARE THEM AND PROCEDURE TO OBTAIN 3-CEFEM COMPOUNDS FROM SUCH DERIVATIVES |
MX890776U MX6579E (en) | 1975-03-07 | 1976-02-17 | PROCEDURE FOR THE PREPARATION OF A COMPOUND OF 3-OXOCEFEM |
NZ184639A NZ184639A (en) | 1975-02-17 | 1976-02-17 | Azetidinones, intermediates for cephem compounds |
RO7694587A RO74958A (en) | 1975-02-17 | 1976-02-17 | PROCESS FOR THE PREPARATION OF CEPHALOSPORINS |
MX890576U MX6578E (en) | 1975-02-21 | 1976-02-17 | PROCEDURE FOR PREPARING 4-MERCAPTOACETIDINONE DERIVATIVES |
US05/658,665 US4079181A (en) | 1975-02-17 | 1976-02-17 | Certain 7-oxo-4-thio-2,6-diazabicyclo-3,2,0-hept-2-ene compounds |
ES445250A ES445250A1 (en) | 1975-02-17 | 1976-02-17 | Certain 7-oxo-4-thio-2,6-diazabicyclo-3,2,0-hept-2-ene compounds |
GB6187/76A GB1548641A (en) | 1975-02-17 | 1976-02-17 | Cyclization to form a cephem ring and intermediates therefor |
NL7601613A NL190721C (en) | 1975-02-17 | 1976-02-17 | Process for the preparation of 3-hydroxy-cephem derivatives. |
MX76898U MX3818E (en) | 1975-02-17 | 1976-02-17 | PROCEDURE FOR THE PREPARATION OF ENAMINES OF HYDROXI-3-CEFEM COMPOUNDS |
GB41074/78A GB1548643A (en) | 1975-02-17 | 1976-02-17 | Thiazoline ring cleavage |
DD7600195995A DD127900A5 (en) | 1975-02-17 | 1976-02-17 | METHOD FOR PRODUCING MERCAPTOAZETIDINE DERIVATIVES |
PL1976212108A PL114624B1 (en) | 1975-03-07 | 1976-02-17 | Process for preparing novel cephem derivatives |
RO7684836A RO68460A (en) | 1975-02-17 | 1976-02-17 | PROCEDURE FOR THE PREPARATION OF AZETIDINONE DERIVATIVES |
DE19762606278 DE2606278A1 (en) | 1975-02-17 | 1976-02-17 | AZETIDINE DERIVATIVES AND METHOD FOR THEIR PRODUCTION |
DD191283A DD124986A5 (en) | 1975-02-17 | 1976-02-17 | |
GR50078A GR60437B (en) | 1975-02-17 | 1976-02-17 | Process for cyclization to form cephem ring and intermediates therefor |
NZ180037A NZ180037A (en) | 1975-02-17 | 1976-02-17 | Derivetives of2-azetidinone and cyclisation to form cephemring |
BG034107A BG27557A4 (en) | 1975-02-17 | 1976-02-17 | Method of obtaining of cephemic compounds |
PH18164A PH18022A (en) | 1975-02-17 | 1976-03-03 | Cyclization to form cephem ring and intermediate thereof |
SU762331355A SU1187717A3 (en) | 1975-03-07 | 1976-03-05 | Method of producing 2-oxo-azetidine compounds |
RO197694535A RO74936A (en) | 1975-02-17 | 1976-07-17 | PROCESS FOR THE PREPARATION OF MERCAPTOAZETIDIONES |
FR7701587A FR2334686A1 (en) | 1975-02-21 | 1977-01-20 | 3-Hydroxy-cephem cpds. prepn. - via new alpha-substd. 3-amino-4-mercapto-2-azetidinone-1-acetic acid derivs |
FR7701590A FR2334684A1 (en) | 1975-03-07 | 1977-01-20 | 3-Hydroxy-cephem cpds. prepn. - via new alpha-substd. 3-amino-4-mercapto-2-azetidinone-1-acetic acid derivs |
SU772442946A SU791247A3 (en) | 1975-03-07 | 1977-01-26 | Method of preparing derivatives of 3-oxy-3-cephem-4-carboxylic acid or respective 3-oxocepham-4-carboxylic acid |
SU772446154A SU795463A4 (en) | 1975-03-07 | 1977-01-26 | Method of preparing 2-oxo-3-acylamino-4-mercaptoazetidines |
US05/856,806 US4160085A (en) | 1975-02-17 | 1977-12-01 | Cyclization to form cephem ring and intermediates therefor |
CS78970A CS207654B2 (en) | 1975-03-07 | 1978-02-15 | Method of preparation of derivatives of 7-acykamino-3-hydroxy-3-cefeme-4-carboxyl acid or the oxofore thereof |
AT417078A AT361120B (en) | 1975-03-07 | 1978-06-08 | METHOD FOR THE PRODUCTION OF AZETIDINE DERIVATIVES |
AT417178A AT351044B (en) | 1975-03-07 | 1978-06-08 | PROCESS FOR THE PRODUCTION OF NEW AZETIDE DERIVATIVES |
IL56050A IL56050A0 (en) | 1975-02-17 | 1978-11-26 | Azetidinones |
IL56049A IL56049A0 (en) | 1975-02-17 | 1978-11-26 | Thiazoline ring cleavage |
IL57418A IL57418A0 (en) | 1975-02-17 | 1979-05-28 | 7-oxo-4-thia-2,6-diazabicyclo(3,2,0)heptene derivatives |
IL57541A IL57541A0 (en) | 1975-02-17 | 1979-06-11 | 7-oxo- -4-thia-2,6-diazabicyclo(3,2,0)heptene derivatives,process for their preparation and pharmaceutical compositons comprising the same |
SE7907812A SE434950B (en) | 1975-02-17 | 1979-09-20 | PROCEDURE FOR PREPARING 3-HYDROXY-CEPHALOSPORO COMPOUNDS |
SE7907811A SE444811B (en) | 1975-02-17 | 1979-09-20 | AZETIDINYL SUBSTANCE FOR THE PREPARATION OF 3-HYDROXY-CEFEM SUBSTANCES AND PROCEDURE FOR ITS PREPARATION |
SE7907813A SE434637B (en) | 1975-02-17 | 1979-09-20 | OZONIZATION PROCEDURE FOR PREPARATION OF ALFA- (AZETIDINYL) -ALFA- (HYDROXYTHYLIDE) -THETIC ACID SUBSTANCES |
CA000337974A CA1077936A (en) | 1975-02-17 | 1979-10-19 | Cyclization to form cephem ring and intermediates therefor |
CA000337975A CA1095026A (en) | 1975-02-17 | 1979-10-19 | Cyclization to form cephem ring and intermediates therefor |
CA000337973A CA1144924A (en) | 1975-02-17 | 1979-10-19 | Cyclization to form cephem ring and intermediates therefor |
CA000338132A CA1132547A (en) | 1975-02-17 | 1979-10-22 | Cyclization to form cephem ring and intermediates therefor |
CH75080A CH628030A5 (en) | 1975-02-17 | 1980-01-30 | Process for the preparation of an enamine compound |
CH75180A CH628031A5 (en) | 1975-02-17 | 1980-01-30 | Process for the preparation of azetidinone compounds |
CH74980A CH634579A5 (en) | 1975-02-17 | 1980-01-30 | Process for preparing cephem compounds |
CH74880A CH630074A5 (en) | 1975-02-17 | 1980-01-30 | Process for preparing an acetidinone compound |
US06/125,233 US4346218A (en) | 1975-02-17 | 1980-02-27 | Cyclization process to form cephem ring |
US06/125,232 US4332722A (en) | 1975-02-17 | 1980-02-27 | Cyclization to form cephem ring and intermediates therefor |
AT0286880A AT363598B (en) | 1975-03-07 | 1980-05-29 | METHOD FOR THE PRODUCTION OF AZETIDINE DERIVATIVES |
US06/338,651 US4440683A (en) | 1975-02-17 | 1982-01-11 | Cyclization to form cephem ring and azetidinone intermediates therefor |
DK76882A DK76882A (en) | 1975-02-17 | 1982-02-22 | INTERMEDIATES FOR THE CREATION OF A SEPHREATHER AND PROCEDURES FOR PRODUCING THEREOF |
YU1741/82A YU40413B (en) | 1975-02-17 | 1982-08-10 | Process for obtaining cephem compounds |
YU1742/82A YU40414B (en) | 1975-02-17 | 1982-08-10 | Process for obtaining new azetidinone derivatives |
YU1739/82A YU40412B (en) | 1975-02-17 | 1982-08-10 | Process for producing mercapto azetidine compounds |
YU1738/82A YU40411B (en) | 1975-02-17 | 1982-08-10 | Process for obtaining mrcapto azetidine compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP50028452A JPS609516B2 (en) | 1975-03-07 | 1975-03-07 | Cyclization method for Cefem skeleton |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS51105088A JPS51105088A (en) | 1976-09-17 |
JPS609516B2 true JPS609516B2 (en) | 1985-03-11 |
Family
ID=12249046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50028452A Expired JPS609516B2 (en) | 1975-02-17 | 1975-03-07 | Cyclization method for Cefem skeleton |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS609516B2 (en) |
AT (2) | AT361120B (en) |
FR (1) | FR2334684A1 (en) |
PL (2) | PL114457B1 (en) |
SU (2) | SU1187717A3 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4013651A (en) * | 1975-05-12 | 1977-03-22 | Eli Lilly And Company | 3-substituted amino-cephalosporins |
US4024152A (en) * | 1975-09-19 | 1977-05-17 | Eli Lilly And Company | 4-Dithio-3-imido-azetidin-2-ones |
CA1148938A (en) * | 1979-05-08 | 1983-06-28 | John R. Corfield | Preparation of cephalosporins and intermediates employed therein |
JP3195959B2 (en) * | 1991-03-13 | 2001-08-06 | 大塚化学株式会社 | Method for producing 3-hydroxycephem derivative |
-
1975
- 1975-03-07 JP JP50028452A patent/JPS609516B2/en not_active Expired
-
1976
- 1976-02-17 PL PL1976212107A patent/PL114457B1/en unknown
- 1976-02-17 PL PL1976212108A patent/PL114624B1/en unknown
- 1976-03-05 SU SU762331355A patent/SU1187717A3/en active
-
1977
- 1977-01-20 FR FR7701590A patent/FR2334684A1/en active Granted
- 1977-01-26 SU SU772442946A patent/SU791247A3/en active
-
1978
- 1978-06-08 AT AT417078A patent/AT361120B/en not_active IP Right Cessation
-
1980
- 1980-05-29 AT AT0286880A patent/AT363598B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
PL114624B1 (en) | 1981-02-28 |
AT361120B (en) | 1981-02-25 |
AT363598B (en) | 1981-08-10 |
ATA286880A (en) | 1981-01-15 |
JPS51105088A (en) | 1976-09-17 |
FR2334684A1 (en) | 1977-07-08 |
FR2334684B1 (en) | 1980-03-28 |
SU791247A3 (en) | 1980-12-23 |
SU1187717A3 (en) | 1985-10-23 |
PL114457B1 (en) | 1981-01-31 |
ATA417078A (en) | 1980-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1136132A (en) | Cyclization to form cephem ring and intermediates therefor | |
US4581170A (en) | N-hydroxyl protecting groups and process and intermediates for the preparation of 3-acylamino-1-hydroxy-2-azetidinones | |
US4066641A (en) | Method for cyclization to give cephem ring | |
US4633017A (en) | N-hydroxy protecting groups and process for the preparation of 3-acylamino-1-hydroxy-2-azetidinones | |
HU187944B (en) | Process for the epimerization of malonic acid esters | |
CA1070672A (en) | Azetidinone compounds | |
JPS609516B2 (en) | Cyclization method for Cefem skeleton | |
SE458609B (en) | 7-ACYL-3-CARBAMOYLOXI-3-METHYL-CEFAM COMPOUNDS, AND PROCEDURES FOR PREPARING THEREOF | |
US4332722A (en) | Cyclization to form cephem ring and intermediates therefor | |
JPS588060A (en) | Arylthioazetidinone sulfonates | |
JPH03178980A (en) | Production of 3-substituted thio-3-cephem compound | |
JPH0321544B2 (en) | ||
US4647558A (en) | Antibacterial agents, their preparation and use | |
JPS604189A (en) | Production of beta-lactam compound | |
JPS61176563A (en) | Manufacture of 4,4-dialkyl-2-azetidinones | |
EP0061763B1 (en) | 4-substituted mercapto-2-oxo-1-azetidinesulfonic acid salts and process for their preparation | |
EP0096496B1 (en) | Preparation of penicillin and cephalosporin compounds and novel intermediates useful therein | |
EP0386940A1 (en) | 6-Beta-(alpha-etherified oxymino)-acyl amino penicillins | |
EP0124123B1 (en) | 3-acylamino-1-sulfonylaminocarbonylmethoxy-2-azetidinones | |
JPH11255767A (en) | 1-isothiazolidinone derivative of azetidin-2-one and its production | |
KR810001488B1 (en) | Process for preparing intermediates of cephem ring | |
JPH0354110B2 (en) | ||
KR800000087B1 (en) | Process for preparing cephem derivatives | |
KR810001820B1 (en) | Process for preparing cephem derivatives | |
JPH0516432B2 (en) |